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ABSTRACT 
CHRISTOPHER T. SMITH: Neurocognitive Investigation of Immediate Reward Selection Bias, 
A Putative Intermediate Phenotype for Alcohol Use Disorders 
(Under the direction of Charlotte A. Boettiger) 
 
 Immediate reward selection (or “Now”) bias is defined as the tendency for individuals to 
preferentially select a smaller, sooner reward over a larger, later reward in a delay discounting 
task. This behavior has been suggested as an intermediate behavioral phenotype for alcohol use 
disorders (AUDs). While Now bias has been shown to be elevated in individuals with AUDs, we 
provide additional support for Now bias as an intermediate phenotype for AUDs by showing it is 
enhanced in heavy drinking adults (ages 26-40) with no reported AUDs. Furthermore, we found 
that Now bias is elevated in light drinking adults with at least one first degree relative with an 
AUD, a key criterion in categorizing a behavior as an intermediate phenotype.  
Prior work has provided insight onto the genetic basis of Now bias with two studies 
reporting a role for a polymorphism associated with prefrontal cortex (PFC) dopamine (DA) 
tone: the Val
158
Met single nucleotide polymorphism (SNP) in the catechol-O-methyltransferase 
(COMT) gene. One study in adolescent males (Paloyelis et al., 2010) found Now bias to be 
heightened in COMT Met/Met individuals while another in adult males and females found Now 
bias was elevated in Val/Val individuals. We sought to further investigate the role of COMT 
Val
158
Met genotype in Now bias behavior to resolve the discrepancy between these previous 
studies. Here, we report data showing that variables that putatively affect frontal DA tone (age, 
iv 
 
estradiol, and COMT genotype) can explain differences in Now bias according to an inverted-U 
function—in other words, those with low or high PFC DA display greater Now bias than do 
individuals with intermediate levels. Furthermore, we found that individuals with lower tonic DA 
(COMT Val allele carriers) benefited most from putative increases in DA signaling (associated 
with increasing estradiol levels). While, the neural bases of Now bias and the role of DA in this 
behavior remain to be studied in further detail, our data suggests that considering individual 
differences in DA signaling according to an inverted-U model may be critical in any future 
treatments aimed at reducing Now bias with dopaminergic drugs or other interventions targeted 
at PFC function.  
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CHAPTER 1: GENERAL INTRODUCTION 
 
Intermediate phenotypes and the study of complex psychiatric disorders 
 Many psychiatric disorders including schizophrenia and depression are complex and 
heterogenous. The highly heritable nature of these disorders, estimated from twin studies to be 
anywhere from 40 to 80% (Sullivan et al., 2000; Sullivan et al., 2003), suggests that some 
biological processes mediated by genetics must confer risk for developing the disorder. It has 
been proposed that the inability to isolate strong biological bases for how genetic variation leads 
to complex, highly heritable diseases lies in the fact that various intermediate behaviors or traits  
are more closely tied to genetics associated with the disease (Rasetti and Weinberger, 2011). For 
example, in schizophrenia  left dorsolateral prefrontal cortex function (dlPFC) hyperactivity and 
poorer performance in an executive function task scales with COMT Val
158
Met genotype more 
severely in those with the disorder (Egan et al., 2001). More sophisticated analyses creating a 
polygenic risk score for schizophrenia (identifying genetic variations in a large sample of those 
with and without the disease) have found that dlPFC activity during the Sternberg Item 
Recognition Paradigm scales with genetic risk for schizophrenia (Walton et al., 2013b). These 
studies suggest that the intermediate phenotype of dlPFC hyperactivity assessed during executive 
function tasks has a genetic basis that explains part of the variance in schizophrenia diagnosis.  
As dlPFC hyperactivity is a quantifiable trait associated with genetic risk, it has been proposed as 
an intermediate phenotype for schizophrenia in several studies (Manoach et al., 1999; Karlsgodt 
et al., 2007; Walton et al., 2013b; Walton et al., 2013a). Given that substance use disorders 
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(SUDs) are also complex disorders with  heritability estimates ranging from 40 to 60% (Heath et 
al., 2001; Verweij et al., 2010; Bierut, 2011; Agrawal et al., 2012), the identification of 
intermediate phenotypes associated with risk for these disorders is a growing focus of recent 
research (Karoly et al., 2013). Behavioral candidates for SUD intermediate phenotypes include 
reduced response inhibition (Acheson et al., 2011a; Norman et al., 2011), increased risk taking 
behavior (Cservenka and Nagel, 2012; Schneider et al., 2012), aberrant reward responsivity 
(Wrase et al., 2007; Andrews et al., 2011), and increased discounting of delayed monetary 
rewards (Mitchell et al., 2005; Boettiger et al., 2007; Claus et al., 2011; MacKillop et al., 2011; 
MacKillop, 2013). 
 
Criteria for categorizing a behavior as an intermediate phenotype 
 For an intermediate phenotype to be useful it must be a quantitative, continuously 
variable feature or behavior that can be consistently measured. Furthermore, as these 
intermediate phenotypes are thought to convey genetic risk for a disorder, they should be 
elevated in those affected with the disorder as well as in those individuals’ close relatives. 
Importantly, the level of these phenotypes in affected individuals and their close relatives should 
be shifted away from a distribution of those otherwise unaffected with no familial risk 
(Gottesman and Gould, 2003). For example, Egan et al. (2001) found unaffected siblings of those 
with schizophrenia to display executive function deficits that fell between unaffected 
nonrelatives and individuals with schizophrenia. A variety of criteria have come to define an 
intermediate phenotype in psychiatry (Almasy and Blangero, 2001; Gottesman and Gould, 2003; 
Waldman, 2005; Meyer-Lindenberg and Weinberger, 2006). First, the phenotype should be 
sufficiently heritable with genetics explaining variance in the behavior. Second, the phenotype 
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should have good psychometric properties as it must be reliably measurable to be a useful 
diagnostic. Third, the phenotype needs to be related to the disorder and its symptoms in the 
general population (i.e., cognitive deficits associated with dlPFC function and schizophrenia). 
Fourth, the phenotype should be stable over time in that it can be measured consistently with 
repeated testing, potentially to assess treatment effects. Fifth, the behavior should show increased 
expression in unaffected relatives of those with the disorder as highlighted by Egan et al. (2001), 
above. Sixth, the phenotype should co-segregate with the disorder in families in that a family 
member with the disorder should show the behavior or trait to a greater degree than an 
unaffected sibling and that this unaffected sibling should display the trait to a greater degree than 
a distant unaffected relative. Finally, the phenotype should have common genetic influences with 
the disorder. For example, as schizophrenia is associated with poor performance (and dlPFC 
hyperactivity) on executive function tasks, genes affecting dlPFC activity and executive 
functions such as COMT should explain variation in schizophrenia risk ( see Egan et al., 2001). 
A common factor in many of the criteria for categorizing a behavior or trait as an intermediate 
phenotype is that the trait or behavior itself be partially heritable and genetically mediated.  
 
Immediate reward selection bias as an intermediate phenotype for alcohol use disorders 
 As delay discounting behavior has been shown to be highly heritable (Anokhin et al., 
2011; Mitchell, 2011), suggesting a strong genetic component,  and is elevated in a variety of 
addictive behaviors (MacKillop et al., 2011), we focused our current work on this behavior. 
Delay discounting (DD) behavior reflects the tendency for animals to discount the value of 
delayed rewards in comparison to those available immediately. DD has also been referred to as 
immediate reward selection (“Now”) bias as the value of rewards available immediately 
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supersedes waiting for a larger, delayed reward in the future (Rachlin and Green, 1972; Mazur, 
1987). This behavior has been suggested to display many of the necessary criteria of an 
intermediate phenotype for a variety of neurobehavioral disorders including substance use 
disorders (SUDs) (Becker and Murphy, 1988; Reynolds, 2006; Perry and Carroll, 2008; Rogers 
et al., 2010), attention deficit hyperactivity disorder (Barkley et al., 2001; Sonuga-Barke et al., 
2008; Paloyelis et al., 2010), and pathological gambling (Alessi and Petry, 2003; Leeman and 
Potenza, 2012). As these behaviors often co-occur, they may share similar biological and genetic 
components (Wilens, 2007; Leeman and Potenza, 2012). 
 An overview of various intermediate phenotype criteria for SUDs met by Now bias has 
been recently outlined (MacKillop, 2013). Particularly relevant to the current work, individuals 
with alcohol use disorders (AUDs) consistently display greater Now bias behavior versus those 
without AUDs (Petry, 2001; Bjork et al., 2004; Mitchell et al., 2005; Boettiger et al., 2007; 
Mitchell et al., 2007; MacKillop et al., 2011). Thus, Now bias is elevated in those individuals with 
an AUD (intermediate phenotype criterion 3). Conceptually, Now bias can be thought to have 
some relation to AUDs, as every relapse or excess drink represents a decision favoring 
immediate over delayed benefits. Furthermore, Now bias behavior has been shown to be 
heritable and associates with substance use, suggesting common genetic influences with SUDs 
(Anokhin et al., 2011). Importantly, Now bias as assessed through delay discounting (DD) tasks, 
has good psychometric properties (responses are highly reliable (Matusiewicz et al., 2013; 
Weafer et al., 2013)), suggesting it is a trait that is robust to consistent measurement 
(intermediate phenotype criterion 2). This is further supported by the fact that DD behavior is 
stable over time (Kirby, 2009). Thus, Now bias satisfies many of the criteria for an intermediate 
phenotype for AUDs. 
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Under-investigated criteria for Now bias as an intermediate phenotype for AUDs 
 As Now bias is elevated in those with AUDs, we might expect to see this behavior 
heightened in those on a trajectory toward an AUD as well. Such demonstrations between elevated 
Now bias and AUD risk would add greatly to the utility of Now bias as an intermediate phenotype. 
As problematic alcohol use during the emerging adulthood may predict development of an AUD 
later in life (O'Neill et al., 2001; Merline et al., 2008; Dick et al., 2011), though many individuals 
mature out of problematic use (Bartholow et al., 2003; Costanzo et al., 2007; Lee et al., 2013), one 
might expect Now bias is enriched in problematic drinking emerging adults. Only one relatively 
small behavior study has looked at such a relationship with Now bias observed to be heightened 
among heavy versus lighter social drinking college students (Vuchinich and Simpson, 1998). This 
finding requires replication in a larger, more diverse sample as Vuchinich and Simpson (1998) 
focused on students with an average age of 19 to 20. 
 In addition to being elevated in problematic drinking emerging adults, to satisfy another 
intermediate phenotype criterion for AUDs, Now bias behavior should also be elevated in 
unaffected first-degree relatives of those suffering from AUDs (intermediate phenotype criterion 
5). Elevated Now bias in first-degree relatives of those with AUDs has yet to be adequately 
demonstrated, however. Most of the intermediate phenotype literature considers the expression 
of the behavior or trait in first-degree relatives (siblings or parents) as critical in demonstrating 
that behavior as an intermediate phenotype. In the field of AUDs, however, positive family 
history of an AUD is often defined as having at least one parent with an AUD (Acheson et al., 
2011b) or father with an AUD (Crean et al., 2002; Petry et al., 2002), or some combination of 
parental history or sufficient density of AUD history in second degree relatives (Herting et al., 
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2010). In these previous studies, the effects of family history on Now bias was either only 
observed in females (Petry et al., 2002), was not found at all (Crean et al., 2002; Herting et al., 
2010), or was not present when controlling for group differences in IQ and antisocial behavior 
(Acheson et al., 2011b). Measuring Now bias behavior in individuals with any first degree 
relatives with AUDs expands the classic family history positive AUD definition to include 
siblings, who display greater genetic concordance with a particular individual than their parents. 
To our knowledge, though, this definition of first degree family member positive or negative for 
AUDs has not been applied to the study of Now bias. Thus, while Now bias possesses many 
properties that suggest it could be a good intermediate phenotype for AUDs, further investigation 
of this possibility is warranted, particularly work focusing on examining whether Now bias is 
elevated in unaffected individuals with first degree relatives with AUDs.  
 
Biological basis of Now bias – role of genetics and frontal dopamine  
 Pharmacological manipulations in rodents (Dalley et al., 2008; Doya, 2008; Winstanley, 
2011) suggest that the neuromodulator dopamine (DA) is an important biological regulator of 
Now bias. Additional work in humans has suggested DA as a modulator of Now bias behavior 
(de Wit et al., 2002; Mitchell et al., 2007), though results have been inconsistent (Acheson et al., 
2006; Hamidovic et al., 2008; Pine et al., 2010). Genetic variations in the human DA system may 
explain these heterogenous findings as they are associated with individual differences in Now 
bias (Boettiger et al., 2007; Eisenberg et al., 2007; Paloyelis et al., 2010; Kelm and Boettiger, 
2013). Three of these genetic studies found variations in the gene encoding the catechol-O-
methyltransferase (COMT) enzyme to be associated with Now bias. COMT is an important 
regulator of tonic DA in the prefrontal cortex (PFC) in animals (Karoum et al., 1994; Gogos et 
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al., 1998; Kaenmaki et al., 2010) and humans (Chen et al., 2004; Slifstein et al., 2008; Wu et al., 
2012). A single nucleotide polymorphism (Val
158
Met SNP) in the gene encoding the COMT 
enzyme results in higher tonic PFC but not striatal DA levels in those with the COMT Met/Met 
SNP (Wu et al., 2012). Recently, Kelm and Boettiger (2013) found that accounting for COMT 
Val
158
Met genotype (hence referred to as COMT genotype) explained substantial variance in the 
effects of DA depletion on Now bias, emphasizing the critical role of this SNP in mediating 
dopaminergic modulation of Now bias. Earlier investigations of the role of COMT genotype in 
Now bias behavior have produced conflicting results, however (Boettiger et al., 2007; Paloyelis 
et al., 2010). Paloyelis et al. (2010) found greater Now bias in Met/Met individuals, and Boettiger 
et al. (2007) found that COMT Val/Val individuals displayed greater Now bias. Further 
exploration of the role of COMT genotype is needed to resolve these seemingly divergent 
findings.  
 
Quantifying Now bias behavior using Impulsive choice ratio  
 To assess Now bias in the studies that follow, we employed a previously validated delay 
discounting task described in detail previously (Mitchell et al., 2005; Altamirano et al., 2011). 
All choices were hypothetical monetary amounts which have been shown to produce similar 
discounting behavior as real monetary choices (Johnson and Bickel, 2002; Madden et al., 2003; 
Madden et al., 2004; Lagorio and Madden, 2005). Participants chose their preferred option on W 
trials, their non-preferred option on the DW trials, and the side with the sooner time or larger 
monetary amount for SOONER and LARGER trials, respectively.  
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Figure 1.1: Overview of Delay Discounting (DD) Task. A. Order of events presented to 
participants during our delayed-discounting task. Participants are instructed to choose between 
two hypothetical monetary amounts: a smaller amount available Today (NOW) or a larger 
amount available at a delay in the future (LATER) based on the question prompt presented at the 
bottom of the screen. B. Question prompt types: SOONER?, LARGER?, WANT?, DON’T 
WANT? The proportion of question prompts presented over the course of the task is illustrated 
in the pie chart with WANT? trials occurring 50% of the time. From participants’ WANT? trial 
responses, we calculate impulsive choice ration (ICR), the main dependent measure of Now bias 
in our studies. ICR is the ratio of Today WANT responses selected over the total WANT 
responses selected by each participant.  
 
 Our main dependent measure, the impulsive choice ratio (ICR) is calculated by dividing 
the number of W trials in which participants select the smaller, sooner Now reward over the total 
number of W responses made. Thus ICR can range from 0 to 1 with an ICR of 0 indicating a 
participant always chose the delayed, larger reward amount (Later) and an ICR of 1 resulting 
when a participant always chose the Now amount in the W trials. 
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This task has several methodological advantages to more common adjusting amount 
procedures (Madden et al., 1997; Richards et al., 1999) used to calculate individual indifference 
points for each participant. First, our task’s control conditions allow us to remove participants 
not performing our task as instructed. Most discounting tasks employing only WANT choice 
prompts have no way to identify participants failing to follow task instructions. Using the 
discounting task employed here, each individual’s reaction times (RTs) for all trial types can be 
plotted to determine whether they are actively evaluating the two choices during our W condition 
(Figure 1.2).  
 
Figure 1.2: Expected versus invalid DD task reaction time patterns. Plots of expected and 
improper reaction time (RT) patterns from 247 participants completing the delay-discounting 
task used in our studies. RT for control trials are expected to be faster than for WANT and 
DON’T WANT trials. In addition, WANT RT is expected to be faster than DON’T WANT RT. 
Of the 247 participants data depicted here, ~96.4% (n=238) performed the task as expected with 
the remaining ~3.8% (n=9) not performing the task as expected. Participants with the invalid task 
RT pattern are excluded from our analyses. RT, reaction time; CON, Control 
(SOONER/LARGER) Trials 
 
Participants performing the task as expected should take longer to make a response to a 
W trial than the control objective valuation CON trials. When participants do not show this 
expected pattern, we remove them from our analyses (Figure 1.2). Thus, the delay discounting 
task we employed insures that all Now bias data analyzed is from participants completing the 
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task as intended versus those responding reflexively and inconsistently during the task. Also, by 
randomly varying the delayed amount, time, and question trial types, this task allows participants 
to make their choices with less interference from previous choices. This differs from adjusting 
amount procedures where choices are titrated based on participants choices in such a way as to 
push them to more likely select the option they did not select previously (switching from Now to 
Later choices or vice versa by increasing the delayed amount or decreasing the delay time, for 
example). Thus, the task employed in the following studies allows for a more robust and 
consistent measurement of Now bias behavior by identifying participants not following task 
instructions and reduces biasing participants responses in the WANT condition by intermixing it 
with other choice conditions. As this task is also compatible with neuroimaging techniques 
(Boettiger et al., 2007; Boettiger et al., 2009), it easily also allows for investigation of the neural 
correlates of discounting behavior, an important future direction of the currently presented work. 
Importantly, ICR is highly correlated with a more traditional measure of delay discounting, k 
(Mitchell et al., 2005). In Mitchell et al. (2005), k was derived from the cumulative dollar ratio 
(CDR) for each delay time (D) according to the following equation (Mazur, 1987): CDR = 
1/(1+kD) and taking the mean k across delay times. The model-free nature of ICR allows for the 
measurement of Now bias across a range of individuals whose subjective choice patterns may not 
conform to the selected discounting function, of which several have been proposed (Takahashi et 
al., 2008). 
 
Rational for aims of current studies  
 Using the task outlined above to assess Now bias, quantified by ICR, the work presented 
here sought first to clarify the role of COMT Val
158
Met genotype in Now bias behavior (Chapter 
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2). We hypothesized that due to age related declines in DA signaling (Mukherjee et al., 2002; 
Wahlstrom et al., 2010) and increases in COMT expression with age (Tunbridge et al., 2007) that 
COMT-related effects on Now bias may vary as a function of age. As the age range in Paloyelis 
et al. (2010) was 11 to 20 (average age 15.4±2) while Boettiger et al.’s (2007) average 
participant’s age was 28.3±5.8, we reasoned age-related changes in tonic DA were the most 
parsimonious explanation for the divergent findings across these two studies. We recruited equal 
numbers of 18-21 and 22-40 year olds, determined their COMT genotype, and measured their 
Now bias behavior. We expected to find that Now bias was elevated in COMT Met/Met 18-21 
year olds close in age to Paloyelis et al. (2010) and elevated in COMT Val/Val 22-40 year olds 
with a similar average age to Boettiger et al. (2007). We expected that taking into account age-
related differences in DA tone across our groups, we could explain Now bias behavior across age 
and COMT groups via an inverted-U model. 
 Secondly, we sought to extend work suggesting Now bias to be a useful intermediate 
phenotype for AUDs (Chapter 3). We wanted to determine if heavy, problem drinking behavior 
in emerging adulthood (a risk factor for development of AUDs) was associated with elevated 
Now bias as seen by Vuchinich and Simpson (1998). Measuring Now bias in a larger sample of 
light and heavy drinkers across a wider age range (Vuchinich and Simpson (1998) ages were 
19.1±1 for heavy and 19.7±2 for light drinkers) would allow us to assess if drinking status and 
age interact to affect Now bias. Additionally, age differences between Vuchinich and Simpson’s 
(1998) two groups may have confounded their findings as the heavy drinkers tended to be 
younger than the light drinkers. As the Alcohol Use Disorders Identification Test (AUDIT) is an 
effective means of measuring problem drinking behavior (Fiellin et al., 2000; Barbor and 
Higgins-Biddle, 2001; Kokotailo et al., 2004), we recruited high and low AUDIT individuals 
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across a group of 18-40 year old social drinkers not reporting any AUD. We hypothesized that 
Now bias would be elevated in high but not low AUDIT emerging adults (defined as 18-21 or 
18-24). Furthermore, we sought to test whether Now bias was elevated in those otherwise 
unaffected individuals (light/moderate social drinkers; low AUDIT) with a first degree relative 
with an AUD. We used the intermediate phenotype criteria of first degree biological relative 
status (father, mother, or sibling with AUD), excluding those with mothers with an AUD to rule 
out potential fetal alcohol effects. We hypothesized that Now bias would be elevated in low 
AUDIT individuals with a first degree relative with an AUD but not in those with no first degree 
AUD relative.  
 
Proposed inverted-U function explaining role of PFC DA on Now bias   
 The interaction between age and COMT effects on Now bias that we observed in Chapter 
2, led to an inverted-U model to describe the effect of prefrontal cortex (PFC) DA levels on Now 
bias that accounts for age and COMT genotype modulation of frontal DA. It has been well 
documented that another cognitive behavior associated with COMT genotype, working memory, 
follows such an inverted-U function (Malhotra et al., 2002; Cools and D'Esposito, 2011; Jacobs 
and D'Esposito, 2011). The proposed working model of COMT’s effects on working memory 
posits that intermediate levels of PFC DA leads to optimal task performance and that insufficient 
or excess PFC DA impairs the ability of the PFC to maintain a goal representation in mind 
(Arnsten, 1997; Vijayraghavan et al., 2007; Arnsten, 2011). This prior work with working 
memory is especially relevant to Now bias as assessed in the current DD task as a network of 
PFC and posterior parietal brain structures (Boettiger et al., 2007) are more active in individuals 
with greater Now bias. These structures are also utilized in working memory tasks (Owen et al., 
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2005) and show heightened activity with increasing task difficulty (Braver et al., 1997; Manoach 
et al., 1997). At least one study has suggested that working memory is negatively correlated with 
Now bias (Shamosh et al., 2008) and depletion of DA effects on working memory performance 
correlated with its effects on Now bias (Kelm and Boettiger, 2013). Thus, examining the role of 
PFC DA on Now bias according to models from the working memory literature seemed to be an 
important concept to probe further. Specifically, we hypothesized that the elevated Now bias 
associated with inefficient PFC function (Boettiger et al., 2007) could be partially explained by 
PFC DA levels according to an inverted-U model with insufficient or excess PFC DA resulting 
in elevated Now bias.  
 
Testing the inverted-U model as a predictor of Now bias behavior change 
To test the implications of the proposed inverted-U as a potential means of predicting 
dopaminergic modulation of Now bias, in Chapter 4, we investigated whether a dynamic factor 
that interacts with frontal DA can shift Now bias within individuals. Specifically, we took 
advantage of the fact that DA signaling increases with acute estradiol administration (Becker, 
1990) and with naturally varying estradiol over the estrus cycle (Xiao and Becker, 1994) in 
rodents. In naturally cycling human females, it has been shown that increasing estradiol and 
associated dopaminergic signaling can impair working memory performance in COMT Met/Met 
individuals with high tonic PFC DA while improving performance in those with COMT Val/Val 
genotype (Jacobs and D'Esposito, 2011). Thus, estradiol’s effects on a PFC DA-dependent 
process follows an inverted-U function when taking tonic PFC DA levels into account. In our 
final study, we assessed Now bias behavior in naturally-cycling female participants at the 
menstrual and follicular phase in their menstrual cycle in a counterbalanced, within-subject 
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design. We hypothesized that COMT Val
158
Met genotype would moderate the relationship 
between increasing dopaminergic signaling associated with rising estradiol from menstrual to 
follicular phase and changes in Now bias. We reasoned our COMT and estradiol effects on Now 
bias would follow an inverted-U model as seen with estradiol × COMT effects on working 
memory (Jacobs and D'Esposito, 2011). This demonstration of an inverted-U model for the role 
of PFC DA on Now bias would have important implications for developing individualized 
treatments for reducing Now bias. We reason that taking account of where an individual’s PFC 
DA tone sits on the inverted-U curve would affect which treatment options should be considered 
– either augmentation or suppression of PFC DA signaling – to reduce Now bias behavior.  
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CHAPTER 2: AGE MODULATES THE EFFECT OF COMT GENOTYPE ON DELAY 
DISCOUNTING BEHAVIOR1 
 
INTRODUCTION 
 Humans and other animals tend to discount the value of delayed, relative to immediate 
rewards, a phenomenon known as delay-discounting (Ainslie, 1975; Mazur, 1987; Frederick et 
al., 2002; Green and Myerson, 2004). Delay-discounting is heightened among individuals with a 
history of substance use disorders (Bickel and Marsch, 2001; Reynolds, 2006), as well as other 
impulse control disorders, such as attention deficit/hyperactivity disorder (ADHD) (Sagvolden 
and Sergeant, 1998; Winstanley et al., 2006; Paloyelis et al., 2009). Such immediate reward bias 
represents one facet of the multi-dimensional construct of impulsivity (Evenden, 1999). A 
variety of evidence links delay-discounting to dopamine (DA) and DA-modulated frontostriatal 
circuits (Boettiger et al., 2007; Doya, 2008; Kobayashi and Schultz, 2008; Lee et al., 2009; 
Paloyelis et al., 2010; Pine et al., 2010; Altamirano et al., 2011; Adriani et al., 2012). Such 
evidence includes data showing that variation in the gene encoding catechol-O-methyltransferase 
(COMT) is associated with differences in the tendency to choose immediate over delayed 
rewards (Boettiger et al., 2007; Paloyelis et al., 2010). COMT is an enzyme that regulates DA 
levels in the prefrontal cortex (Gogos et al., 1998; Tunbridge et al., 2004; Yavich et al., 2007; 
                                                          
1
 The data and text for this chapter are published as: Smith and Boettiger (2012). Age modulates 
the effect of COMT genotype on delay discounting behavior. Psychopharmacology, 222 (4), 
609-617. Erratum of originally-reported CON and WANT RT can be found in 
Psychopharmacology, 231 (3), 621.  
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Kaenmaki et al., 2010), where it is the primary regulator of DA levels (Karoum et al., 1994; 
Kaenmaki et al., 2010). A polymorphism in the COMT gene (COMT Val
158
Met; rs4680) causing 
a valine (Val)-to-methionine (Met) substitution at codon 158 results in a 4-fold reduction of  
COMT enzymatic activity (Lachman et al., 1996),  which is presumed to result in reduced 
cortical DA in Val/Val homozygotes relative to the Met/Met genotype (Chen et al., 2004).  
We have previously reported that COMT Val
158
Met genotype predicts variation in delay-
discounting behavior in adult humans, including those with a history of alcoholism; specifically, 
those with the Val/Val genotype demonstrate greater delay discounting than do met-allele 
carriers (Boettiger et al., 2007).
 
In contrast, a recent study of male adolescents with and without 
ADHD found that those with the Met/Met genotype demonstrate greater delay-discounting than 
do Val-allele carriers (Paloyelis et al., 2010). The sample size in our 2007 study was rather small, 
thus, in the present study, we sought to confirm our earlier finding in a larger sample. In 
addition, we sought to determine whether the relationship between COMT genotype and 
impulsive choice changes from late adolescence to adulthood. Several measures of frontal DA 
neurotransmission decrease from adolescence to adulthood (see (Wahlstrom et al., 2010) for 
recent review). Moreover, COMT expression increases with age in humans (Tunbridge et al., 
2007), which should contribute to reduced frontal DA signaling from adolescence to adulthood. 
Behaviors that depend on frontal DA commonly operate within a range of optimal functioning, 
with both excessive and deficient levels of DA impairing behavioral performance (Goldman-
Rakic, 1998). Thus, an increase in COMT with age could mean that the low activity COMT 
genotype could yield an “overdose” of DA in adolescence, but a more optimal level in 
adulthood, whereas the high activity COMT genotype may compensate for other aspects of 
enhanced DA signaling in adolescence, but produce a DA deficit in adulthood, as DA signaling 
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declines. Specifically, we hypothesized that the effects of genetically determined variation in 
COMT function on delay-discounting behavior are oppositely modulated by age, specifically 
from late adolescence to young adulthood. To test this hypothesis, we genotyped late adolescent 
and adult participants for the COMT Val
158
Met polymorphism, measured their delay-discounting 
behavior, and tested for interacting effects of age group and COMT genotype on discounting 
behavior. As cognitive studies commonly consider participants 18 and over to be adults, we were 
particularly interested in testing this hypothesis in late adolescents that are frequently assumed to 
be adults (ages 18-21 years). 
 
METHODS 
Subjects 
Participants (n = 142) were recruited from the University of North Carolina, Chapel Hill 
(UNC) and surrounding community. Participants were healthy individuals 18-40 years old with 
no known past or present neurological or psychiatric diagnoses, no history of substance use 
disorders, and no current use of psychoactive medications or other psychoactive substances aside 
from moderate caffeine, nicotine or alcohol. All subjects were native English speakers, had at 
least a high-school education, and reported having consumed alcohol at least once in their 
lifetime. Participants were recruited into one of two age groups: late adolescents (18-21 years; n 
= 72) or adults (22-40 years; n = 70). These age group criteria were based on preliminary results 
from other studies in our lab indicating behavioral differences in our task between these two age 
groups. This age cutoff is supported by a recent large scale investigation of functional brain 
maturation that indicated that brain maturation asymptotes at approximately age 22 (Dosenbach 
et al., 2010). Information regarding participants’ personal and parental occupation and education 
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was collected via a questionnaire and quantified as Hollingshead socioeconomic status SES 
scores (Hollingshead, 1975). Participants gave written informed consent, as approved by the 
UNC Office of Human Research Ethics. Subjects received monetary compensation for 
participating. 
 
Delay Discounting Task 
 The paradigm was based on a previously described task (Mitchell et al., 2005; Boettiger 
et al., 2007; Mitchell et al., 2007; Altamirano et al., 2011). Briefly, in each session, subjects 
completed a short (~4 min) practice run and then 8 full runs of approximately 42 or 43 trials each 
(~7 min). There were four trial types:  WANT (W), DON’T WANT (DW), SOONER, and 
LARGER. Trial types were randomly ordered and weighted such that 50% were W condition 
trials and the remaining trials were evenly divided between the other conditions. Trials began 
with an instruction cue, followed by two options, each of which was a monetary value and a 
time. Subjects were asked to evaluate the options as if they would actually receive the specified 
amounts at the corresponding times. The options consisted of one of five “full” amounts ($2, $5, 
$10, $20, or $100) at one of five future delays (1 week, 2 weeks, 1 month, 3 months, or 6 
months) and a discounted amount (70, 85, 90, or 95% of the “full” amount) offered at no delay 
(“TODAY”).  Subjects were instructed to make a choice in each trial, according to the trial type: 
preferred option on W trials, non-preferred option on DW trials, and the side with the sooner 
time or larger amount of money for SOONER and LARGER trials, respectively. These latter two 
conditions are considered together as control (“CON”) trials. The order of trial types was the 
same for all subjects; however, the delayed amount, delay time, and discount were 
pseudorandomly ordered. The length of the task (~56 min) could raise the concern that choice 
behavior is affected by fatigue or other temporally-dependent effects. This could be a particular 
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concern if such effects varied with age or genotype. These concerns can be dismissed on the 
basis of the following analyses. First, a repeated measures ANOVA found no significant effect of 
block number on ICR (F(7, 917) = 0.49, p = 0.84), nor any significant ICR by block interaction 
with age (F(7, 917) = 0.31,  p = 0.95) or genotype (F(14, 917) = 0.22, p = 1). Second, when we 
calculated the split-half ICR for odd and even blocks, the correlation across all subjects was r = 
0.98 (p < 0.001). Similarly, the correlation between first half ICR and second half ICR was 
r=0.96 (p < 0.001). Finally, for the sample as a whole, Cronbach’s 0.99. Furthermore, 
Cronbach’s  was also 0.99 when calculated separately for each age group and each genotype. 
We note that these reliability measures are well above the standard criterion for adequate 
reliability of 0.70 (Kline, 2000). 
Genotyping 
 COMT Val
158
Met (rs4680) genotyping was performed on DNA extracted from saliva 
samples (DNA Genotek, Kanata, Ontario, Canada) using TaqMan technology (Applied 
Biosystems, Foster City, CA), as described previously (Boettiger et al., 2007). Genotyping was 
performed by the UNC Mammalian Genotyping Core and/or the Duke Center for Human 
Genetics. Genotyping was performed in duplicate for n=42 samples and compared to ensure 
validity of the data. The genotype concordance rate was 100% both within (n = 42) and across (n 
= 32) genotyping facilities. Allele frequencies in this sample did not deviate from Hardy–
Weinberg equilibrium (2 = 0.098, df = 2, p = 0.95). 
 
Data Analysis 
 Our index of temporal discounting was the proportion of “TODAY” choices in W trials, 
which we have termed the impulsive choice ratio (ICR). Although this value was calculated 
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separately according to delay time and delayed amount, here we focus on the ratio collapsed 
across all W trials.  
To test the significance of across group comparisons, we used unpaired two-tailed t-tests 
for continuous measures and tests for categorical measures. For multi-factorial comparisons, 
we used regular or mixed repeated measures ANOVA in SPSS (SPSS Inc., Chicago, IL), with 
age group and genotype as between subjects factors. When necessary, a Greenhouse-Geisser 
non-sphericity correction was applied. Post-hoc paired comparisons were performed where 
indicated using two-tailed t-tests. When data were not normally distributed, appropriate arcsine-
root transformations were applied in Excel (Microsoft Corp., Redmond, WA) prior to making 
statistical comparisons to ensure the validity of parametric statistical tests. Simple regression 
analyses were performed in SPSS. 
 
RESULTS 
Demographic and psychometric data 
 To test whether COMT Val158Met genotype differentially predicts ICR among late 
adolescents versus adults, we genotyped two groups of subjects: late adolescents (18-21 years; n 
= 72) and adults (22 - 40 years; n = 70). There were no significant differences between the two 
groups in terms of gender, ethnicity, or parental socio-economic status (SES; see Table 2.1). As 
expected, the late adolescent group was significantly younger than the adult group, and also 
reported lower personal SES levels (driven primarily by a lower level of education), and slightly 
greater alcohol use (AUDIT score) than did the adult group (Table 2.1). 
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Table 2.1: Demographic data by age group 
 Late Adolescent 
(ages 18-21) 
(n = 72) 
Adult  
(ages 22-40) 
(n = 70) 
    t(140)        p  value     
     
Age (yrs) 20 ± 1 27 ± 5       11.53    <0.001 
Education (yrs) 14 ± 1 17 ± 2       11.90    <0.001 
Subject Hollingshead SES 
Parent Hollingshead SES 
40 ± 3 
54 ± 9 
47 ± 7 
54 ± 11 
      7.49      <0.001 
      0.13        ns 
Sex (% female)  53  54                      ns
† 
Ethnicity (% white)  62  66                      ns
†
 
       Black (%) 13 19                      ns† 
       Hispanic (%) 4 4                      ns
†
 
       Asian (%) 14 7                      ns
†
 
       Other/mixed (%)  7 4                      ns
†
 
 
AUDIT score 
 
8.9 ± 6.3 
 
7.2 ± 4.1 
 
     1.99        0.049 
    
Values are reported as mean ± standard deviation. Reported p-values reflect the results of 
unpaired two-tailed comparisons between groups. Exact p-values reported unless p < 0.001. 
AUDIT, Alcohol Use Disorders Identification Test; SES, socioeconomic status. 
†
p-value 
represents results of χ2 test. 
 
Interaction between age and COMT genotype on frequency of impulsive choices  
 On the basis of COMT Val
158
Met genotype, participants were subdivided into Met-
homozygotes (Met/Met; n = 33), heterozygotes (Val/Met; n = 69) and Val/Val homozygote 
individuals (n=40). COMT genotype groups did not differ significantly in terms of demographic 
features (education, age, sex, ethnicity, SES, and alcohol use), or task performance (control 
reaction times and control trial accuracy; Table 2.2). We did observe a main effect of COMT 
genotype on WANT trail reaction time, however (Table 2.2). On the basis of our a priori 
hypothesis for an age×genotype interaction in delay-discounting behavior, we conducted a 
factorial ANOVA with age group and COMT Val
158
Met genotype as between-subjects factors, 
taking an index of delay-discounting, the impulsive choice ratio (ICR; see Methods), as the 
dependent measure. Although our groups were matched for sex (Tables 2.1 and 2.2), we included 
sex as a factor in our analyses as a means of detecting sexually dimorphic effects of COMT on 
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delay discounting, as sex-dependent effects on COMT enzyme activity have been reported (Chen 
et al., 2004). We included SES, alcohol use (AUDIT score), and WANT trial reaction time  as 
covariates due to the fact that we observed significant differences in SES and AUDIT scores 
between our age groups (Table 2.1) and WANT trial RT between our COMT groups (Table 2.2).  
Table 2.2: COMT genotype groups: demographics and task performance 
 V/V 
(n=40) 
V/M 
(n = 69) 
M/M  
(n = 33) 
  F(2,139)    p-value 
Demographics     
Age (yrs) 24 ± 5 23 ± 6 23 ± 5       0.57      ns 
Education (yrs) 16 ± 2 15 ± 2 15 ± 2       1.85      ns 
Hollingshead SES 44 ± 7 43 ± 6 45 ± 7       0.35      ns 
Sex (% female)  45  54  64                    ns
† 
Ethnicity (%white)  50  68  73                    ns
†
 
      Black (%) 25 15 6                    ns
†
 
      Hispanic (%) 7.5 1 6                    ns
†
      
      Asian (%) 12.5 10 9                    ns
†
 
      Other/mixed (%) 5 6 6                    ns
†
 
 
AUDIT Score 
 
Task performance 
 
8.5 ± 5.0 
 
 
7.5 ± 5.0 
 
8.6 ± 6.6 
 
      0.67      ns 
 
CON Trial Acc 96.6 ± 3.9 97.6 ± 2.5 97.1 ± 2.7       1.60      ns 
CON Trial RT 
WANT Trial RT 
1325 ± 306 
1701 ± 380 
1363 ± 289 
1890 ± 420 
1375 ± 314 
1904 ± 377 
      0.29      ns 
      3.41      0.036 
Values are reported as mean ± standard deviation. Reported p-values reflect the results of 
unpaired two-tailed comparisons between groups. Exact p-values reported unless p < 0.001. Acc, 
accuracy; AUDIT, Alcohol Use Disorders Identification Test; COMT, catechol-O-
methyltransferase; CON, control; M/M, methionine/methionine; RT, reaction time; SES, 
socioeconomic status V/M, valine/methionine; V/V, valine/valine. 
†
p-value represents results of 
χ2 test. 
 
In a 2×2×3 ANOVA (age group × COMT genotype × sex), we did not detect significant 
main effects of age group (F(1, 127) = 0.81, p = 0.371, η
2 
= 0.005), COMT Val
158
Met genotype (F(2, 
127) = 0.10, p = 0.908, η
2 
= 0.001) or sex (F(1, 127) = 1.22, p = 0.272, η
2 
= 0.008) on ICR. 
Moreover, we observed no significant interaction between sex and COMT genotype (F(2, 127) = 
1.00, p = 0.371, η2 = 0.013), or three-way interaction between sex, COMT genotype, and age 
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group (F(2, 127) = 0.43, p = 0.650, η
2 
= 0.006). In contrast, consistent with our hypothesis, there 
was a significant age-by-COMT Val
158
Met interaction effect on delay-discounting behavior. (F(2, 
127) = 5.12,  p= 0.007, η
2 
= 0.069; Figure 2.1). We also detected a smaller interactive effect 
between sex and age-group (F(1, 127) = 4.03, p = 0.047, η
2 
= 0.027).  
 
Figure 2.1:  Age interacts with COMT genotype to influence impulsive decision-making. (a) 
Plot of impulsive choice ratio (ICR) as a function of COMT genotype, showing a significant age 
by genotype interaction (F(2,127) = 5.12, p=0.007). This effect reflects significant age-related 
changes in ICR for all three genotypes. M/M, methionine/methionine; V/M, valine/methionine; 
V/V, valine/valine. *p < 0.05. 
 
Given our somewhat ethnically mixed sample (see Tables 2.1 and 2.2) and the reported 
racial differences in COMT Val
158
Met allele frequencies (e.g. (McLeod et al., 1994; McLeod et 
al., 1998), it is worth noting that the age-by-COMT Val
158
Met interaction was also seen in our 
white participants, the largest ethnic group included (F(2, 82) = 11.77, p < 0.001, η
2 
= 0.209). 
Among non-white participants, we observed a similar, albeit non-significant, trend (F(2, 42) = 1.61, 
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p = 0.21, η2 = 0.065), likely due to the heterogeneity within this smaller group. This interaction 
effect reflects a significant age-related increase in delay-discounting among Val-homozygotes 
(t(38) = 2.48, p = 0.018) and a significant age-related decline in delay-discounting among both 
Met-homozygotes (t(31) = 2.20, p = 0.036) and COMT Val
158
Met heterozygotes (t(67) = 2.01, p = 
0.048). Considering age as a continuous variable, we observed a negative correlation between 
age and ICR among Met-allele carriers (r = -0.31, p = 0.001). In contrast, among Val/Val 
individuals we observed a significant positive correlation between age and ICR (r = 0.32, p = 
0.047).  
While we have previously reported that choice behavior in this task does not correlate 
with education or SES (Mitchell et al., 2005; Mitchell et al., 2007), the present study included a 
somewhat younger demographic. Thus, we carried out bivariate correlations to assess whether 
demographic factors predicted decision-making behavior in this cohort of participants. We found 
that the tendency to choose a smaller immediate reward did not correlate with years of education 
(r = -0.09, t = -1.04, p = 0.299). Similarly, SES was not significantly correlated with ICR (r = -
0.14, t = -1.66, p=0.1). We also observed no correlation between age and ICR (r = -0.14, t = -
1.62, p = 0.107), which is not unexpected based on the opposing age effects for Met-carriers and 
Val homozygotes.  
The mean overall ICR values (shown in Figure 2.1), including SD, were as follows for 
the Late Adolescent group: Val/Val, 0.56 ± 0.39; Val/Met, 0.70 ± 0.24; Met/Met, 0.70 ± 0.28. 
Corresponding values for the Adult group were: Val/Val, 0.79 ± 0.21; Val/Met, 0.57 ± 0.31; 
Met/Met, 0.45 ± 0.32. We have previously reported that discounting in this task is modulated by 
reward magnitude (Mitchell et al., 2005; Mitchell et al., 2007), such that participants show 
greater discounting for smaller rewards. This finding was replicated in the present study (Figure 
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2.2) as shown by a 3-way ANOVA (delayed reward amount × age group × genotype), which 
found a significant main effect of delayed reward amount (F(2.15, 292.96) = 146.24, p < 0.001, η
2 
= 
0.512).  
 
Figure 2.2: Comparison of reward magnitude discounting functions. Semi-log plot of ICR as a 
function of the delayed reward amount. Data reflect mean ± SEM. Curves represent logarithmic 
fit the group averaged data.  
 
We did not observe significant interactions between delayed reward amount and either 
age group (F(2.15, 292.96) = 0.79, p = 0.465, η
2 
= 0.003) or genotype (F(4.31, 292.96) = 0.67, p = 0.624, 
η2 = 0.005). Likewise, we observed no significant three-way interaction (F(4.31, 292.96) = 0.66, p = 
0.632, η2 = 0.005). Thus the genotype × age group interaction that we observed does not appear 
to be specific to certain magnitudes of reward.  
 
DISCUSSION 
The present results confirm our previous finding of enhanced delay-discounting among 
COMT Val
158
Met Val/Val adults relative to Met-allele carriers (Boettiger et al., 2007). Moreover, 
these results help account for the discrepancy between our earlier findings and the results of 
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Paloyelis et al. (2010) showing enhanced delay-discounting among COMT Val
158
Met Met/Met 
adolescent males. Furthermore, as our study included females and found no main effects of sex, 
nor any interaction of sex with our genotype by age effect, these data extend the previous finding 
in adolescent males of Paloyelis et al. (2010) to late adolescent females. 
 
Relationship between alcohol use and delay-discounting 
We previously found a significant positive relationship between ICR and alcohol use in 
studies including both control subjects and those with a history of alcoholism (Mitchell et al., 
2005; Boettiger et al., 2007; Mitchell et al., 2007). We have also reported a positive correlation 
between ICR and the dependence and harm subscales of the AUDIT (Mitchell et al. 2005). 
However, consistent with the present data, we have not found a significant relationship between 
ICR and AUDIT scores in studies restricted to those with no history of alcoholism (Altamirano 
et al., 2011). This discrepancy may reflect inadequate power to detect an effect due to 
insufficient variance in AUDIT dependence and harm scores in samples excluding AUDs. For 
example, the median AUDIT dependence and harm score here was 2 (interquartile range: 1 - 
4.75). In contrast, the median in Mitchell, et al. (2005) was the same, but the interquartile range 
was more >3× larger (0.75 - 16). Alternatively, the relationship between ICR and AUDIT may 
be weak.  
 
Cortical dopamine regulation of delay-discounting 
Consistent with our hypothesis, we found that age modulates COMT Val
158
Met genotype 
effects on delay-discounting behavior. Adult met-allele carriers showed significantly less delay-
discounting relative to late adolescent met-carriers, while Val/Val adults showed significantly 
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more delay-discounting relative to late adolescent Val/Val individuals. To account for both the 
adolescent and adult data we report, we propose a single U-shaped model of the relationship 
between frontal DA levels and impulsive choice (Figure 2.3).  
 
Figure 2.3: Model depicting hypothetical regulation of impulsive choice by frontal dopamine. 
Closed symbols represent adolescents, whole open symbols represent adults. Arrows indicate the 
effects of a developmental decline in frontal dopamine function for each genotype. Model posits 
that reduced frontal DA signaling in adulthood relative to late adolescence results in opposing 
effects on impulsive choice that vary with COMT genotype, based on an underlying U-shaped 
relationship. An age-dependent drop in frontal DA signaling in Val/Val individuals is predicted 
to yield greater ICR in adults relative to adolescents. In contrast, an equivalent age-dependent 
drop in frontal DA signaling is predicted to result in reduced ICR in Met-carrier adults relative to 
adolescents. For simplicity, equivalent declines in frontal DA signaling are proposed for all 
COMT genotypes, although differential changes may occur. COMT, catechol-O-
methyltransferase; DA, dopamine; M/M, methionine/methionine; V/M, valine/methionine; V/V, 
valine/valine.  
 
Such a model is supported by evidence that dopaminergic modulation of frontal functions 
often follows a U-shaped curve, where deficient or excess DA can impair frontal functioning 
(Arnsten, 1997; Zahrt et al., 1997; Goldman-Rakic et al., 2000; Williams and Castner, 2006). 
Our model posits that reduced frontal DA signaling in adulthood relative to late adolescence 
results in opposing effects on impulsive choice in different COMT genotypes, based on this U-
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shaped relationship. Specifically, an age-dependent drop in frontal DA signaling in Val/Val 
individuals yields greater ICR in adults relative to adolescents. In contrast, an equivalent age-
dependent drop in frontal DA signaling results in reduced delay-discounting in Met-carrier adults 
relative to adolescents. For simplicity, we have proposed equivalent declines in frontal DA 
signaling across COMT genotypes; however, developmental declines in frontal DA signaling 
may vary by COMT genotype. Support for this possibility comes from recent data showing 
COMT Val
158
Met genotype-dependent methylation resulting in reduced Val allele expression 
(Ursini et al., 2011). Developmental regulation of methylation is one mechanism by which 
declines in frontal DA signaling could vary by COMT genotype. An important prediction of this 
model is that within typical “healthy young adult” samples (ages18-40), the admixture of late 
adolescents and young adults would tend to obscure COMT genotype effects. While this model is 
currently hypothetical, future PET studies may test the validity of this U-shape model of the 
effects of age-dependent differences in frontal DA signaling on impulsive choice.  
One remaining important question is whether age-dependent differences in COMT 
genotype effects on decision-making behavior differ among different ethnic groups. While the 
present data conclusively find an age by COMT genotype interaction among white participants, 
they lack sufficient power to draw this same conclusion for other ethnic groups. Heterogeneity 
within the non-white sample may contribute to this lack of power. Moreover, the relationship 
between age and discounting behavior could vary with ethnicity, introducing another source of 
variance. Larger explicit studies of the effects of ethnicity may resolve this question. 
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Broader implications of age-dependent differences in COMT genotype effects  
In addition to playing a role in modulating impulsive choice, the Val/Val genotype is also 
associated with poorer performance on executive tasks and greater frontal activation relative to 
Met-carriers (Egan et al., 2001; Blasi et al., 2005; Minzenberg et al., 2006; Winterer et al., 
2006a; Winterer et al., 2006b; Tan et al., 2007), which is thought to reflect frontal processing 
inefficiency, particularly during tasks requiring maintenance of stable representations (Bilder et 
al., 2004; Nolan et al., 2004; Tunbridge et al., 2006). However, published data regarding the role 
of the COMT Val
158
Met genotype in cognition is mixed (Barnett et al., 2008; Dennis et al., 
2010). Thus, in addition to reconciling the literature regarding the effect of COMT Val
158
Met 
genotype on delay-discounting behavior, these data also suggest an explanation for discrepancies 
in the literature regarding COMT genotype effects on executive function.  
We note that the present study was cross-sectional in nature; a prospective study is 
required to determine whether the age modulation of COMT genotype effects on delay-
discounting reflects developmental processes. Such processes may specifically affect delay-
discounting behavior or may also impact linked behaviors, such as working memory (Shamosh 
and Gray, 2008; Shamosh et al., 2008). Specificity of underlying neural circuits may result in 
task-dependent sensitivity to frontal DA levels, whereby the optimal level for certain tasks is 
sub-optimal for other tasks (Cools and Robbins, 2004; Nolan et al., 2004). Moreover, frontal 
circuit maturation remains incomplete until the early-to-mid twenties (Sowell et al., 1999; Casey 
et al., 2000; Sowell et al., 2001; Giedd, 2004; Gogtay et al., 2004; Lenroot and Giedd, 2006),, 
and components of this circuitry critical for particular tasks may mature at different rates.  
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Implications for effects of manipulating DA signaling 
As noted earlier, several measures of frontal DA signaling decrease from adolescence to 
adulthood (see (Wahlstrom et al., 2010) for recent review). COMT expression increases across 
the lifespan in humans (Tunbridge et al., 2007), which should result in an age-dependent 
decrement in frontal DA. An important implication of the age-dependent differences in COMT 
genotype effects on delay-discounting is that accounting for both age and COMT genotype may 
be required to accurately predict the effects of medications that alter frontal DA. Relevant 
clinical disorders are those associated with impaired frontal DA function, such as schizophrenia, 
addiction, and ADHD. As these disorders frequently onset in late adolescence (or sooner, in the 
case of ADHD), understanding how age may impact medication response could help to optimize 
clinical outcomes for these conditions.  
 
Study limitations 
 A limitation of the present study is that it cannot completely reconcile the differences 
between the findings of Paloyelis et al. (2010) and Boettiger et al. (2007), since the adolescent 
group in the present study did not include participants younger than 18, as did that of Paloyelis 
and colleagues.  Another limitation is the lack of investigation of other genetic variations that 
may impact delay-discounting behavior, a substantially heritable trait (Anokhin et al., 2011; 
Mitchell, 2011). For example, the DA D4 receptor (DRD4) and D2 receptor (DRD2) genes have 
been linked to variation in delay-discounting behavior (Eisenberg et al., 2007), although these 
findings are not unequivocal (White et al., 2008; White et al., 2009; Paloyelis et al., 2010). As 
such it is important to consider these results primarily as further evidence that proxy indicators of 
frontal DA signaling can predict some of the individual differences in delay-discounting. In 
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addition, our results highlight the importance of considering age as a possible confounding factor 
in future studies evaluating genetic contributions to delay-discounting behavior. Future studies 
designed to test for interactions between COMT and other polymorphisms in adults may help to 
clarify the interacting roles for frontal and striatal DA signaling in regulating delay discounting 
behavior; such studies will also require larger sample sizes than that reported here. Beyond age, 
we did not find additional environmental variables that accounted for substantial variance in 
discounting behavior within our sample.  However, future larger-scale studies that explicitly test 
for effects of alcohol use, gender, as well as related cognitive phenotypes may allow for a more 
complete understanding of the neurobiology of discounting behavior. In particular, measures of 
working memory, reward sensitivity, and response inhibition may each be regulated by separate 
DA-regulated networks, which in turn make differing contributions to delay-discounting 
behavior.  
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CHAPTER 3: INTERTEMPORAL CHOICE BEHAVIOR IN EMERGING ADULTS 
AND ADULTS: EFFECTS OF AGE INTERACT WITH ALCOHOL USE AND FAMILY 
HISTORY STATUS 
 
INTRODUCTION 
Adults with addictive disorders, including alcohol use disorders (AUDs), tend to choose 
smaller, sooner over larger, delayed rewards in the context of delay-discounting (DD) tasks more 
frequently than do adults with no addiction history (Petry, 2001; Mitchell et al., 2005; MacKillop 
et al., 2011). This immediate reward selection (or “Now”) bias persists even after years of 
abstinence and does not correlate with abstinence duration (Mitchell et al., 2005), suggesting 
irreversible consequences of chronic alcohol abuse and/or a pre-existing risk trait, or 
intermediate phenotype (Meyer-Lindenberg and Weinberger, 2006; MacKillop, 2013). If the 
latter were true, we would predict heightened Now bias among young people who engage in at-
risk drinking but who do not meet clinical criteria for alcohol dependence, relative to age-
matched moderate drinkers. We would also predict heightened Now bias among moderate 
drinkers with problem-drinking first degree relatives. 
We have previously found marked Now bias among emerging adults (18-25 yrs), 
regardless of drinking behavior (Kelm et al., 2010). This suggests elevated DD generally among 
individuals transitioning from adolescence to adulthood. The observation that adult controls 
(average age of 26-28) with no AUD diagnosis display reduced Now bias compared to abstinent 
alcoholic adults (Mitchell et al., 2005; Boettiger et al., 2007) suggests that this bias should 
decline between emerging adulthood and adulthood, at least among moderate, non-problem 
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drinkers. While emerging adults are widely regarded as impulsive (Chambers and Potenza, 2003; 
de Wit, 2009), and DD normally decreases from childhood to the early 30’s (Green, 1994; Scheres 
et al., 2006; Olson et al., 2007; Eppinger et al., 2012), little is known about specific changes in DD 
from late adolescence to adulthood. Some data show trait impulsivity declining linearly with age 
from early adolescence to age 30 (Steinberg et al., 2008). Thus, given positive correlations 
between DD and trait impulsivity (Mitchell et al., 2005; de Wit et al., 2007), DD should decline 
with age from adolescence into the 30s, but, to our knowledge, no prior studies have explicitly 
investigated age effects on DD in detail from ages 18 to 40. Moreover, we do not know whether 
heavy alcohol use moderates any such age-related changes in DD.  
Thus, we tested whether an age-related decrease in DD occurs from emerging adulthood 
to adulthood, and whether any such age effect on DD is absent among sub-clinical heavy 
drinkers. To do so, we recruited individuals with no substance use disorder (SUD) history who 
had consumed alcohol at least one time previously into one of two age groups: late adolescents 
(18-21) and adults (22-40). We initially recruited across these age groups as we have found that a 
genetic regulator of Now bias differentially affects DD behavior in these groups (Smith and 
Boettiger, 2012). We wanted to recruit in such a way as to control for this effect. Within each 
age group, we recruited equal numbers of light/moderate drinkers and heavy, possible problem 
drinkers, based on Alcohol Use Disorders Identification Test (AUDIT) scores. Low AUDIT 
individuals were defined as AUDIT scores <8 for males and <5 for females , and high AUDIT 
individuals were defined as AUDIT scores ≥8 for males and ≥5 for females (Neumann et al., 
2004). We quantified DD using a previously validated task (Mitchell et al., 2005; Altamirano et 
al., 2011) and assessed the effects of age, alcohol use, their interaction, and family history (FH) 
of alcoholism on Now bias. 
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METHODS 
Participants 
Participants (n=246; ~50% female) aged 18-40 were recruited from the University of 
North Carolina (UNC) and surrounding community. We recruited participants based on AUDIT 
(Saunders et al., 1993) scores, age, and sex. High AUDIT groups were defined by AUDIT scores 
≥8 for males, and ≥5 for females (n=142, mean: 11.8±4.7), and low AUDIT groups had AUDIT 
scores <8 for males and <5 for females (n=104, mean: 3.3±2.1). Our “late adolescent” group 
included participants ages 18-21 and our “adult” group included participants ages 22-40, based 
on preliminary findings from two other studies in our lab, as well as data showing brain 
maturation asymptoting ~22 yrs (Dosenbach et al., 2010). Participants had consumed alcohol one 
or more times in their lifetime, had no known history of any neurological, SUD, or other 
psychiatric disorders, and no current psychoactive drug use, excluding nicotine, caffeine, and 
alcohol. Although no participants self-reported any AUD, post-hoc evaluation of responses in the 
Rutgers Alcohol Problem Index (RAPI) indicated probable alcohol dependence among 43 
recruited subjects (17.5%; 91% High AUDIT), based on Diagnostic and Statistical Manual of 
Mental Disorders (4th ed.; DSM–IV; (American Psychiatric Association, 1994) criteria; 
however, excluding these participants from our analyses did not qualitatively change our 
findings. Therefore, we did not exclude these participants, although we do additionally report 
data with these subjects excluded where noted. Nine subjects were excluded from all analyses 
due to unreliable task performance (see below). Thus, 237 participants (n=118 male) are 
included in our analyses; sex ratios were purposely balanced within each recruitment group. 
Subjects provided written, informed consent, as approved by the UNC Office for Human 
Research Ethics. 
 35 
 
Behavioral Inventories 
We administered standard questionnaires to quantify personal substance use, alcoholism 
familial history (FH), and behavioral traits. These included the AUDIT, the RAPI (White and 
Labouvie, 1989), the Drug Abuse Screening Test (DAST) (Skinner, 1982), and the Drug Use 
Screening Inventory, Domain I (DUSI-I); (Tarter, 1990). DUSI-I scores reported as % 
affirmative answers from Domain I, part B. We calculated density of familial alcohol abuse from 
the Family Tree Questionnaire (FTQ) (Mann et al., 1985), and classified participants reporting a 
problem drinking father or sibling as FH positive for alcoholism (FHP; n=76). Those reporting a 
problem-drinking mother (n=22) were excluded from our FH analyses to avoid potential 
confounds from fetal alcohol exposure. Those reporting no problem drinking first degree 
relatives were classified as family history negative (FHN; n=161). The Barratt Impulsiveness 
Scale-11 (BIS); (Patton et al., 1995) was used as a subjective measure of trait impulsiveness. 
Socio-economic Status (SES) was quantified as Hollingshead scores, following the Barratt 
Simplified Measure of Socioeconomic Status method  (Hollingshead, 1975; Barratt, 2006).  
Delay Discounting Task 
The task has been described in detail previously (Altamirano et al., 2011; Smith and 
Boettiger, 2012). In brief, subjects practiced, then completed 8 blocks of 42 trials. There were 
four conditions: WANT (W), DON’T WANT (DW), SOONER, and LARGER; the latter two are 
considered together as control (CON) trials. Trial types were pseudorandomly ordered. Each trial 
displayed two monetary reward options, one ($2 - $100) available at a delay (1 wk – 6 mos) and 
a lesser amount (5 – 30% less) available “TODAY”. All choices were hypothetical. Participants 
chose their preferred option on W trials, their non-preferred option on the DW trials, and the side 
with the sooner time or larger monetary amount for SOONER and LARGER trials, respectively. 
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The delayed amount, delay time, percent discount, and left/right position were pseudorandomly 
selected for each trial. We also collected reaction time (RT) for each trial. Nine subjects were 
excluded based on faster RT in the W and/or DW trials than in the CON trials, indicating lack of 
subjective consideration of options.  
Genotyping  
 We previously found that a polymorphism in the catechol-O-methyltransferase (COMT) 
gene (COMT Val
158
Met; rs4680) interacts with age to affect ICR (Smith and Boettiger, 2012). To 
control for this potential confound, participants were genotyped for the COMT Val
158
Met 
polymorphism as previously described (Boettiger et al., 2007; Smith and Boettiger, 2012). 
Although COMT genotype distribution did not differ across recruitment groups (see Tables 3.1-
3.3), we included a COMT*age covariate in our analyses to account for the COMT by age effect 
we previously observed.  
 
Data Analysis 
Our primary index of DD was the proportion of smaller, sooner choices made in the W 
condition, the impulsive choice ratio (ICR). We also calculated ICR as a function of delay time 
and of delayed reward amount, and we calculated area under the ICR by delay time curve 
(AUC). Inferred ICR (iICR) at each delay time was calculated based on the non-selected option 
in DW trials. We calculated the absolute difference between ICR and iICR at each delay time, 
and averaged this value across all delay times as a gross index of motor control (motor 
mismatch, MM). Also, criterion interest rate was calculated as reported previously (Mitchell et 
al., 2007) as a measure of how much more the delayed reward needed to be valued over the now 
reward to be accepted ~75% of the time.  
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For single factor statistical comparisons between groups, we used unpaired two-tailed t-
tests for continuous measures and χ2 tests for categorical measures. For multi-factorial 
comparisons, we used standard or repeated measures mixed model ANOVAs with group as a 
between subjects factor, using SPSS (IBM, Montauk, NY). When necessary, a Greenhouse-
Geisser non-sphericity correction was applied. When data were not normally distributed, arcsine-
root transformations were applied in Excel to ensure the validity of parametric statistical tests. 
All analyses performed in SPSS unless otherwise noted. Effect sizes for ANOVA are reported as 
η2, while effect sizes for t-tests are reported as Cohen’s d. 
 
Exploratory analyses to define optimal future age and alcohol-use groups 
For exploratory analyses focused on the effect of age and AUDIT consumption (AUDIT-
c) scores on ICR, we calculated d-prime (d′), a discriminability index derived from signal 
detection theory (Green & Swets, 1966). To identify, post-hoc, age and AUDIT-c cutoff scores 
producing the largest group difference in ICR, we calculated d′ for ICR group differences as: 
 
Where ICRgroupn=average ICR for group n, SDICRgroupn=standard deviation of ICR for group n. 
Cutoffs for group determinations were set as the grouping criteria that produced a d′ for our ICR 
group difference comparison of 1 or more. To confirm our d′ findings, we also calculated 
Cohen’s d effect sizes (Cohen, 1988) for each grouping, using a pooled measure of SD (Hartung 
et al., 2008). 
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Figure 3.1: Systematic analysis of adult age cutoff on ICR age group effects among moderate 
drinkers. Plot depicts the group discrimination index (d′) as a function of adult age cutoff. 
Among moderate drinkers in this sample, d′ is maximal with an adult age cutoff of 26 years of 
age. Note that a gap year was included in each age group comparison.  
 
Analysis of age group effect size in Low AUDIT individuals 
 Our recruitment groups were empirically based, but the age cut-offs between groups may 
not be optimal for detecting age effects on ICR. To inform future studies requiring smaller 
sample sizes, we used signal detection theory to evaluate the ability of different age cutoffs to 
discriminate the mean ICR of emerging adults from “full” adults (within low AUDIT 
individuals), taking d′ as our discrimination index (see above). We focused this analysis on the 
Low AUDIT group to investigate the effects of age on ICR without the additional effect of 
heavy, problematic alcohol use on this behavior. Grouping participants into older and younger 
age groups, leaving a gap year between groups, we used a sliding window to calculate ICR 
means and SDs for each grouping. We then quantified the discriminability (d′) between each age 
group pair for each age cutoff (from ages 21-31). Maximal discrimination of ICR between age 
groups occurred with an adult age cutoff of 26 (i.e. comparing ages 18-24 to ages 26-40; Figure 
3.1). In confirmation, Cohen’s d effect sizes for each age grouping found the largest age group 
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effect with an age cutoff of 26 (Cohen’s d=0.82). Based on these discriminability results, for our 
subsequent age group analyses, we classified participants as emerging adults (ages 18-24, n=184; 
mean age=20.8±1.7) or adults (ages 26-40, n=39; mean age=31.4±4.0). 
RESULTS 
Demographic and psychometric data by recruitment groups 
Based on preliminary data from our lab, we initially recruited late adolescent (ages 18-
21) and young adult (ages 22-40) subjects, with roughly equal ratios of high AUDIT individuals 
within each group. Details on the demographic differences between these recruited age groups 
can be found in Table 3.1. Importantly, our recruited age groups did not differ in terms of 
ethnicity, sex, SES, family history of alcohol abuse (FTQ density), COMT genotype distribution, 
nor in terms of several measures of substance use (DUSI, DAST; Table 3.1). 
Considering the subjects according to AUDIT recruitment groups, we observed no 
significant differences between groups in terms of age, education, SES, sex, ethnicity, COMT 
genotype distribution, FH of alcohol abuse, or FTPI scores (Table 3.2).  
Considering demographic, substance use, and psychometric measures across our 
age*AUDIT recruitment groups, we found that these four groups did not differ in terms of sex, 
COMT genotype, or ethnicity (Table 3.3). Moreover, we found no significant age*AUDIT 
interactions on any measure except AUDIT scores and DUSI scores (Table 3.3). This result 
reflects ~26% higher AUDIT scores and ~21% higher DUSI scores among 18-21 year olds 
relative to 22-40 year olds within the high AUDIT group (Table 3.3).  
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Demographic and psychometric data: Emerging Adults vs Adults 
We investigated whether any demographic, substance use, or psychometric measures 
varied across our emerging adult (18-24), adult (26-40) and low and high AUDIT recruitment 
groups via a 2x2 ANOVA. We found that these four groups did not differ in terms of sex, COMT 
genotype, or ethnicity (Table 3.4). Moreover, we found no significant age*AUDIT group 
interactions on any measure except AUDIT and DUSI scores (Table 3.4). This result reflects 
~47% higher AUDIT scores and ~39% higher DUSI scores among 18-24 year olds relative to 
adults within the high AUDIT group (Table 3.4). 
Table 3.1: Demographic, substance use, and psychometric data by age recruitment group 
 Ages 18-21 
(n = 111) 
Ages 22-40 
(n = 126) 
t (235) p value 
General     
Age (yrs) 19.7 ± 1.2 25.5 ± 4.6     -13.58 <0.001 
Education (yrs) 13.8 ± 1.2 16.5 ± 1.7 -13.17
a
 <0.001 
SES  51.4 ± 8.2 51.1 ± 8.9 0.20 0.84 
Gender (% female) 49.5 50.8 
 
0.85
†
 
Ethnicity (% non-white) 33.3 24.6  0.14
†
 
COMT genotype (% ValVal) 22.5 31.7  0.32
†
 
     
Substance use-related     
AUDIT - total 9.2 ± 6.5 7.4± 4.6 2.41 0.017 
      AUDIT consumption  4.9 ± 2.6 4.8 ± 2.2 0.44
b
 0.66 
      AUDIT D/H 4.2 ± 4.4 3.0 ± 3.1 2.34
b
 0.02 
RAPI 8.8 ± 8.0 6.7 ± 7.4 2.16 0.032 
DUSI 0.3 ± 0.2 0.3 ± 0.2 1.60 0.11 
DAST 2.1 ± 2.5 2.0 ± 2.4 0.43 0.67 
FTQ density (%) 16.9 ± 18.0 14.8 ± 16.6 0.93 0.356 
 
Psychometric     
BIS - total 60.5 ± 9.6 57.8 ± 9.6 2.17
c
 0.031 
      BIS Attention 15.9 ± 3.7 15.3 ± 3.5 1.3
c
 0.19 
      BIS Motor  22.1 ± 3.5 21.3 ± 3.8 1.74
c
 0.084 
      BIS Non-Planning 22.4 ± 4.6 21.2 ± 4.6 2.12
c
 0.035 
FTPI mean extension (yrs) 8.6 ± 5.4 6.6 ± 5.4 2.89 0.004 
FTPI max extension (yrs) 31.1 ± 23.3 24.4 ± 19.9 2.37 0.018 
Values are reported as mean ± standard deviation. Reported p-values reflect the results of unpaired two-tailed 
comparison between groups. Exact p-values reported unless p < 0.001. AUDIT, Alcohol Use Disorders 
Identification Test; AUDIT D/H, AUDIT dependence/harm subscales; RAPI, Rutgers Alcohol Problem Index; 
DUSI, Drug Use Screening Inventory, part I-B; DAST, Drug Abuse Screening Test; SES, Socioeconomic Status; 
BIS, Barratt Impulsiveness Scale; FTPI, Future Time Perspective Inventory. 
†
p-value represents results of χ2 test.  
a
df=233, 
b
df=215; 
c
df=234  
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Table 3.2: Demographic, substance use, and psychometric data by AUDIT recruitment group 
 Low AUDIT  
(<8 M, <5 F, n=99) 
High AUDIT 
(≥8 M, ≥5 F, n=138) 
t (235) p value 
General     
Age (yrs) 23.0 ± 4.8 22.7 ± 4.3 0.55 0.58 
Education (yrs) 15.4 ± 2.0 15.2 ± 2.0 0.76
a
 0.45 
SES  51.1 ± 9.4 51.4 ± 8.0 -0.27 0.79 
Gender (% female) 44.4 54.3 
 
0.13
†
 
Ethnicity (% non-white) 29.3 28.3  0.86
†
 
COMT genotype (% ValVal) 24.2 29.7  0.63
†
 
     
Substance use-related     
AUDIT - total 3.4 ± 2.1 11.8 ± 4.7 -18.77 <0.001 
      AUDIT consumption  2.9 ± 1.5 6.3 ± 1.9 -13.4
a
 <0.001 
      AUDIT D/H 0.8 ± 1.2 5.7 ± 3.7 -14.0
a
 <0.001 
RAPI 2.6 ± 4.0 11.3 ± 7.7 -11.5 <0.001 
DUSI 0.1 ± 0.1 0.4 ± 0.2 -13.72 <0.001 
DAST 1.0 ± 1.3 2.8 ± 2.8 -6.7 <0.001 
FTQ density (%) 14.9 ± 16.5 16.5 ± 17.8 -0.72 0.475 
 
Psychometric     
BIS - total 56.7 ± 8.9 60.8 ± 9.9 -3.23
b
 0.001 
       BIS Attention 15.2 ± 3.3 15.9 ± 3.9 -1.55
b
 0.122 
       BIS Motor  21.2 ± 3.4 22.1 ± 3.9 -1.88
b
 0.062 
       BIS Non-Planning 20.4 ± 4.4 22.8 ± 4.5 -4.05
b
 <0.001 
FTPI mean extension (yrs) 7.8 ± 5.3 7.3 ± 5.6 0.62 0.54 
FTPI max extension (yrs) 27.9 ± 20.9 27.3 ± 22.4 0.21 0.84 
     
Values are reported as mean ± standard deviation. Reported p-values reflect the results of unpaired two-tailed 
comparison between groups. Exact p-values reported unless p < 0.001.  Conventions as per Table 3.1. M, males; F 
females. 
†
p-value represents results of χ2 test.  adf=233, bdf=215; cdf=234  
 
AUDIT does not predict ICR in emerging adults 
 Among our emerging adults (ages 18-24), we found no significant ICR differences 
between high AUDIT (0.63±0.32) and low AUDIT (0.68±0.25) groups (t(180.448)=1.29, p=0.20, 
d=0.18). Considering AUDIT as a continuous variable, we also found no significant correlation 
between AUDIT and ICR among emerging adults (r(182)= 0.014, p=0.42, β=0.001). Furthermore, 
ICR did not correlate with any other substance use measures in this age group (max r=0.065, min 
p=0.383). Thus, the relationship between ICR and alcohol use robustly observed in adult samples 
(Mitchell et al., 2005; Boettiger et al., 2007; Mitchell et al., 2007) is not detectable in an 
emerging adult population.  
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Table 3.3: Demographic, Substance Use Related, and Psychometrics Measures Across Age and 
AUDIT groups 
 Low AUDIT  
(<8 M, <5 F, n=99) 
High AUDIT 
(≥8 M, ≥5 F, n=138) 
 
 Ages 18-21 
(n = 45) 
Ages 22-40 
(n = 54) 
Ages 18-21 
(n = 66) 
Ages 22-40 
(n = 72) 
Significant 
Age*AUDIT 
interaction 
 
     F233 p 
Demographic       
Age (yrs)  19.6 ± 1.2 25.8 ± 4.9 19.8 ± 1.1 25.3 ± 4.4 0.85 0.36 
Education (yrs)  13.8 ± 1.4 16.7 ± 1.4 13.9 ± 1.2 16.3 ± 2.0 1.08
a
 0.30 
SES  51.6 ± 9.2 50.6 ± 9.6 51.2 ± 7.6 51.5 ± 8.4 0.31 0.58 
Ethnicity                     
(% non-white)  
31.1  27.8  34.8  22.2  0.42
†
 
Sex (% female) 42.2  46.3 54.5  54.2  0.49
†
 
COMT genotype        
(% ValVal) 
 20 27.8 24.2 34.7  0.59
†
 
 
Substance use-related  
      
AUDIT  3.3 ± 2.3 3.4 ± 1.9 13.2 ± 5.2 10.5 ± 3.6 7.91 0.005 
AUDIT consumption  2.7 ± 1.4  3.1 ± 1.5  6.5 ± 2.0  6.0 ± 1.8  2.98
b
 0.086 
AUDIT D/H  0.8 ± 1.1 0.7 ± 1.2 6.8 ± 4.2 4.8 ± 2.9 5.92
b
 0.016 
RAPI  3.3 ± 4.7 1.9 ± 3.1 12.6 ± 7.5 10.2 ± 7.7 0.38 0.54 
DUSI 0.12 ± 0.13 0.13 ± 0.12 0.41 ± 0.15 0.34 ± 0.16 3.97 0.048 
DAST  1.02 ± 1.5 0.91 ± 1.1 2.8 ± 2.9 2.7 ± 2.8 0.003 0.96 
FTQ density (%) 15.1 ± 16.6 14.7 ± 16.6 18.2 ± 18.9 15 ± 16.7 0.359 0.55 
       
Psychometric       
BIS - total  57.6 ± 8.8 56 ± 9.1 62.5 ± 9.7 59.2 ± 9.9 0.44
c
 0.51 
      BIS Attention 15.3 ± 3.3 15.1 ± 3.3 16.4 ± 3.9 15.5 ± 3.7 0.69
c
 0.41 
      BIS Motor  21.7 ± 3.3 20.7 ± 3.4 22.4 ± 3.7 21.8 ± 4.0 0.11
c
 0.74 
      BIS Non-Planning 20.7 ± 4.1 20.1 ± 4.7 23.7 ± 4.5 22 ± 4.4 1.004
c
 
0.32 
FTPI mean ext (yrs) 9.0 ± 5.0 6.7 ± 5.4 8.3 ± 5.8 6.4 ± 5.3 0.134 0.72 
FTPI max ext (yrs) 32.3 ± 22.1 24.2 ± 19.3 30.2 ± 24.3 24.6 ± 20.4 0.188 0.67 
       Values are reported as mean ± standard deviation. Reported p-values reflect the results of unpaired two-tailed 
comparison between groups. Exact p-values reported unless p < 0.001.  Conventions as per Table 3.1. 
†
p-value 
represents results of χ2 test. adf=231; bdf=213, cdf=232 
 
Effects of age and AUDIT group on ICR 
Based on our hypothesized age-related decrease in ICR specific to moderate drinkers, we 
conducted a 2-way (age group*AUDIT group) ANOVA, covarying for DUSI scores (see Table 
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3.4). This analysis did not detect a significant main effect of AUDIT group (F(1,217)=0.042, 
p=0.84, η2<0.001). However, a trend toward a main effect of age group (F(1,217)=3.66, p=0.057, 
η2=0.016) and a significant age*AUDIT interaction (F(1,217)=5.17, p=0.024, η
2
=0.023; Figure 3.2) 
on ICR was present. Post-hoc analyses of age-related changes in ICR by AUDIT recruitment 
groups found that among low AUDIT individuals (AUDIT <8 males, <5 females), mean ICR 
was ~48% higher in 18-24 year olds (0.68±0.25) relative to 26-40 year olds (0.46±0.37; F(1, 
91)=8.46, p=0.005, η
2
=0.085). In contrast, in the high AUDIT group, mean ICR was ~1.6% 
higher in 18-24 year olds (0.63±0.32) relative to those 26-40 (0.62±0.32; F(1,124)=0.009, p=0.93, 
η2<0.001). This finding is suggestive that ICR may decline more with age in low versus high 
AUDIT individuals.  
 
Figure 3.2: Interacting effects of age and alcohol use on delay discounting behavior. Plot depicts 
the ratio of immediate reward choices (ICR) in the delay-discounting task as a function of Low 
and High AUDIT and adult and emerging adult age groups, demonstrating a significant 
age*AUDIT interaction (F(1,217)=5.17, p=0.024, η
2
=0.023). This finding reflects the fact that 
among low AUDIT individuals (AUDIT <8 for males, <5 for females), ICR was significantly 
higher in emerging adults relative to adults (F(1, 91)=8.46, p=0.005, η
2
=0.085), but among 
possible problem drinkers (AUDIT ≥8 for males, ≥5 for females), ICR did not differ between age 
groups. AUDIT, Alcohol Use Disorders Identification Test. *p<05. 
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Table 3.4: Demographic, Substance Use Related, and Psychometrics Measures Across Age and 
High/Low AUDIT groups 
 Low AUDIT  
(<8M, <5 F) 
High AUDIT 
(≥8 M, ≥5 F) 
  
 Ages 18-24 
(n = 75) 
Ages 26-40 
(n = 20) 
Ages 18-24 
(n = 109) 
Ages 26-40 
(n = 19) 
Age*AUDIT 
interaction 
      F219 p 
Demographic       
Age (yrs)  20.7 ± 1.7 31.2 ± 4.0 20.9 ± 1.7 31.5 ± 4.2 0.02 0.89 
Education (yrs)  14.7 ± 1.6 17.6 ± 1.5 14.7 ± 1.5 17.6 ± 2.8 <0.001
a
 0.998 
SES  50.6 ± 10 53.1 ± 7.7 51.4 ± 7.7 52.9 ± 9.6 0.13 0.71 
Ethnicity (% non-white)  25.3 40.0 29.4 26.3  0.63
†
 
Sex (% female) 42.7 55.0 52.3 63.2  0.34
†
 
COMT genotype        
(% ValVal) 
22.7 30.0 29.4 36.8  0.73
†
 
       
Substance use-related        
AUDIT  3.5 ± 2.2 3.0 ± 1.9 12.5 ± 4.8 8.5 ± 2.5 7.19 0.008 
AUDIT consumption  3.0 ± 1.4 2.7 ± 1.4 6.6 ± 1.9 4.8 ± 1.1 6.53
b
 0.011 
AUDIT D/H 0.9 ± 1.2 0.6 ± 1.2 6.2 ± 3.8 3.7 ± 2.3 4.77
b
 0.03 
RAPI  2.9 ± 4.0 1.5 ± 3.7 12.3 ± 7.5 7.9 ± 7.7 1.77 0.19 
DUSI 0.12 ± 0.13 0.12 ± 0.13 0.39 ± 0.15 0.28 ± 0.19 4.44 0.04 
DAST  1.0 ± 1.4 0.85 ± 0.9 2.7 ± 2.7 2.6 ± 3.5 <0.001 0.99 
FTQ density (%) 13.9 ± 15.5 21.5 ± 19.5 15.4 ± 16.8 22.2 ± 20.8 0.019 0.89 
       
Psychometric       
BIS - total  56.9 ± 8.7 55.7 ± 9.8 61.7 ± 9.4 55.3 ± 9.9 2.55
c
 0.11 
      BIS Attention 15.4 ± 3.0 14.4 ± 4.0 16.1 ± 3.7 14.6 ± 3.8 0.16
c
 0.69 
      BIS Motor  21.2 ± 3.5 20.8 ± 3.1 22.4 ± 3.8 20.0 ± 3.3 2.45
c
 0.12 
      BIS Non-Planning 20.3 ± 4.3 20.6 ± 5.0 23.2 ± 4.5 20.7 ± 4.6 2.95
c
 0.09 
FTPI mean ext (yrs) 8.6 ± 5.3 5.1 ± 4.0 7.5 ± 5.8 6.9 ± 5.0 2.24 0.14 
FTPI max ext (yrs) 30.7 ± 21.8 19.8 ± 15.2 28.0 ± 23.6 23.1 ± 14.2 0.62 0.43 
       
Values are reported as mean ± standard deviation. Reported F and p-values reflect the results testing for significant 
age by AUDIT group interactions. Exact p-values reported unless p < 0.001.  Conventions as per Table 3.1. 
†
p-value 
represents results of χ2 test. aerror=217, berror=202; cerror=218  
Among low AUDIT individuals, ICR decreases with age 
While we found a trend toward a main effect of age group on ICR that was significant in 
post-hoc tests in the low AUDIT, treating age as a continuous variable provides greater insight 
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on the effect of increasing age on ICR. Overall, a significant negative correlation between ICR 
and age was observed (r(235)=-0.134, p=0.019, β=-0.012) indicating a ~1.1% ICR decrease for 
each year of age >18. Examining the relationship between ICR and age by AUDIT recruitment 
groups, we found a striking difference between the high and low AUDIT groups. The low 
AUDIT group showed a ~2.2% decline in ICR with each year of age >18 (r(197)=-0.276, p=0.003, 
β=-0.022). In contrast, we observed no relationship between ICR and age within the high AUDIT 
group (r(136)=-0.025, p=0.39, β=-0.002). Thus, the age effect on ICR in the whole sample was 
driven by the low AUDIT group. 
 Examination of secondary measures of DD behavior within the low AUDIT group 
produced qualitatively similar results. Specifically, the average area under the ICR by delay time 
curve (AUC) of 18-24 year olds (123.1±52.5) was ~22% larger, relative to that of 26-40 year 
olds (101.0±64.3; t(49.287)=2.011, p=0.05, d=0.41), indicating greater Now bias in emerging 
adults. Moreover, among low AUDIT individuals, we found a significant negative correlation 
between AUC and age (r(97)=-0.309, p=0.001). No such decline in AUC with age was seen in the 
high AUDIT group (r(136)=-0.034, p=0.345).   
 
Other aspects of DD task performance 
Importantly, we found no significant main or interacting effects of age or AUDIT group 
on basic measures of DD task performance, including accuracy in CON trials, and RTs for any 
condition (Table 3.5). Moreover, we found no significant main or interacting effects of age or 
AUDIT group on unintentional motor responding (MM; see Methods; max F=0.785, min 
p=0.38). Thus, group differences in MM cannot explain the group differences in ICR observed 
here. A recent study found greater DD in adolescents (ages 13-15) relative to adults (ages 19-50) 
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that was associated with greater choice inconsistency (Ripke et al., 2012). Here, we found that 
the consistency of ICR across task blocks (8 blocks of the task were administered over ~50 
minutes) did not differ between age groups (Cronbach’s α, ages 18-24: 0.984, ages 26-40: 
0.990). Furthermore, a two-way repeated measures ANOVA (age group*block) found no 
significant main effect of block (F(7,1491)=0.96, p=0.46) nor block*age group interaction 
(F(7,1491)=0.58, p=0.77) on ICR. Thus, our observed age effects on ICR are not attributable to 
age–related changes in response consistency. Task related performance and these other measures 
of discounting are reported across low and high AUDIT and emerging adults versus adults in 
Table 3.5. Note that there was no significant age*AUDIT group interaction on any performance 
related measure and that the only significant interaction was observed with our AUC measure, 
which confirms the AUDIT*age group interaction we observed with our ICR measure (see 
Effects of age and AUDIT group on ICR above).  
 
Relationship between AUDIT and ICR: moderation by age 
We further investigated the lack of an age effect on ICR among high AUDIT individuals 
by evaluating the relationship between ICR and AUDIT scores within our age groups. In contrast 
to 18-21 year olds, among 22-40 year olds, we found a trend toward a positive correlation 
between AUDIT score and ICR (Table 3.6). This relationship appears to be driven by a 
relationship between ICR and AUDIT consumption subscale (AUDIT-c) scores, as we observed 
no significant relationship between ICR and AUDIT dependence/harm subscales in adults (Table 
3.6). Among 18-21 year olds, we found no significant relationship between ICR and AUDIT 
subscale scores (Table 3.6). Repeating these analyses using our post-hoc emerging adult and 
adult age groups (see Methods), we found a significant positive relationship between ICR and 
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AUDIT scores among adults (ages 26-40), an effect driven mostly by AUDIT-c scores (Table 
3.6). In adults 26-40, each additional AUDIT-c point was associated with a 15.6% increase 
(β=0.117) in ICR (Table 3.6). In contrast, increases in AUDIT-c scores had no significant effect 
on ICR among emerging adults (18-24; Table 3.6). In this sample, then, it is alcohol 
consumption (as measured via the AUDIT-c) that is related to ICR and the relationship between 
AUDIT-c and ICR becomes apparent when the effects of young age (which we observe is 
naturally associated with high ICR) have diminished after age 25.  
 
Exploratory d′ analysis of AUDIT-c cutoffs 
As ICR correlated better with AUDIT-c than with full AUDIT scores in adults, we sought 
to identify the AUDIT-c score cutoff that produced the largest group difference in ICR so that 
recruitment for future studies investigating this effect could be adequately powered. As for our 
post hoc age group analysis (see Methods), we used a sliding cutoff value to identify the 
maximal between group d′, starting with an AUDIT-c score cutoff of 2. The ICRs of AUDIT-c 
groups began to be maximally discriminated using a cutoff score of 5. Cohen’s d effect size for 
ICR difference across AUDIT-c groups with a cutoff of 5 was (0.73).  
 
Testing for interacting effect of age and alcohol use in AUDIT-c groups  
The fact that we observed age related differences in ICR that were driven by low AUDIT 
individuals and that AUDIT-c appeared to be the primary predictor of ICR in adults 26-40 
suggested that ICR may vary as a function of emerging adult (18-24) versus adult (26-40) and 
low versus high AUDIT-c groups. We conducted a 2-way (age group*AUDIT-c) ANOVA, with 
ICR as our dependent measure. We classified participants as emerging adults (ages 18-24, 
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n=184; mean age=20.8±1.7) or adults (ages 26-40, n=39; mean age=31.4±4.0), and moderate 
drinkers (AUDIT-c <4, n=60; mean AUDIT: 2.8±2.2, mean AUDIT-c: 2.1±0.9) or heavy 
drinkers (AUDIT-c ≥5, n=102; mean AUDIT: 12.1±5.1, mean AUDIT-c: 6.8±1.6). Participants 
with AUDIT-c scores of 4 were excluded, as scores ≥4 may be associated with alcohol misuse in 
females but not males (Bradley et al., 2007). Demographic data across these AUDIT-c and age 
groups are displayed in Table 3.7.  
Table 3.5: Delay Discounting Task Behavioral Measures Across Age and High/Low AUDIT 
groups 
 Low AUDIT  
(<8 M, <5 F) 
High AUDIT 
(≥8 M, ≥5 F) 
 
 Ages 18-24 
(n = 75) 
Ages 26-40 
(n = 20) 
Ages 18-24 
(n = 109) 
Ages 26-40 
(n = 19) 
Age*AUDIT 
interaction 
      F219 p 
Task Performance       
Control Trial Acc  97.0 ± 3.3 96.7 ± 3.5 96.6 ± 3.6 98.1 ± 2.0 2.22 0.14 
Control Trial RT  1364 ± 339 1347 ± 315 1401 ± 329 1233 ± 276 1.68 0.20 
WANT Trial RT 1920 ± 383 1743 ± 388 1915 ± 396 1711 ± 389 0.04 0.84 
DON’T WANT      
Trial RT 
2064 ± 399 1859 ± 385 2086 ± 449 1888 ± 369 0.002 0.96 
       
ICR by Delay Curve Measures       
Area Under Curve 130.6 ± 42.9 86.8 ± 69.2 118.0 ± 57.8 116.0 ± 56.7 4.74 0.031 
Delay Curve Slope  0.13 ± 0.09 0.09 ± 0.11 0.09 ± 0.08 0.10 ± 0.08 1.50 0.22 
Delay Curve Intercept 0.21 ± 0.46 0.10 ± 0.44 0.27 ± 0.41 0.24 ± 0.44 0.23 0.63 
       
Other Task Measures       
Criterion Int. Rate 19.0 ± 18.7 8.3 ± 10.2 17.7 ± 30.5 18.4 ± 19.9 1.61
a
 0.21 
Motor Mismatch  0.11 ± 0.06 0.10 ± 0.07 0.11 ± 0.06 0.12 ± 0.07 0.61 0.44 
ICR consistency (α) 0.978 0.991 0.987 0.988 0.86† 0.51† 
       
Values are reported as mean ± standard deviation. Reported F and p-values reflect the results testing for significant 
age by AUDIT group interactions. Exact p-values reported unless p < 0.001.  Conventions as per Table 3.1. 
a
error=210 
†
result of ICR by Block by Age by AUDIT Group ANOVA, Greenhouse-Geisser corrected: F (7,1477) 
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Table 3.6: AUDIT Correlates with ICR More Strongly in Adults and is Driven by AUDIT 
Consumption Subscale.   
Recruited Age Groups 
 AUDIT Total AUDIT Consumption AUDIT Dependence/Harm 
18-21  
(n=111) 
r(109)=-0.017, p=0.43 
β=0 
r(97)=0.059, p=0.28     
β=0.008 
r(97)=-0.012, p=0.45              
β=0 
22-40 
(n=126) 
r(124)=0.141, p=0.057 
β=0.013 
r(116)=0.158, p=0.044 
β=0.031 
r(116)=0.101, p=0.137 
β=0.014 
    
Post-hoc Age Groups  
 AUDIT Total AUDIT Consumption AUDIT Dependence/Harm 
18-24 
(n=184) 
r(184)=0.014, p=0.42 
β=0.001 
r(166)=0.018, p=0.41 
β=0.003 
r(166)=0.017, p=0.41   
β=0.002 
26-40 
(n=39) 
r(37)=0.30, p=0.032 
β=0.04 
r(36)=0.398, p=0.007 
β=0.117 
r(36)=0.24, p=0.073    
β=0.048 
 
Table reflects Pearson correlation r, p, and beta values from linear regression analyses of AUDIT score and AUDIT 
subscales score effects on ICR by recruited age groups and age groups proposed for further analysis of age effect.  
 
Running our AUDIT-c by age group ANOVA, we found, as expected, significant main 
effects of age (F(1,157)=6.12, p=0.014, η
2
=0.035) and AUDIT-c (F(1,157)=4.37, p=0.038, η
2
=0.025) 
on ICR. Critically, we also observed a significant age*AUDIT-c interaction on ICR (F(1, 
157)=8.32, p=0.004, η
2
=0.047; Figure 3.3). Among moderate drinkers, mean ICR was 80% higher 
in emerging adults (n=44, mean: 0.72±0.21) relative to adults (n=16, mean: 0.41±0.35; 
t(18.679)=3.38, p=0.003, d=1.28). Whereas among heavy drinkers, mean ICR did not differ 
between age groups (t(100)=-0.21, p=0.84, d=-0.06). Moreover, among adults, the mean ICR of 
heavy drinkers (0.69±0.32, n=13) was 72.5% higher than that of moderate drinkers (0.41±0.35, 
n=16; t(27)=-2.28, p=0.031, d=-0.88; Figure 3.3). In contrast, among emerging adults, mean ICR 
did not differ between moderate and heavy drinkers (t(115.216)=1.018, p=0.311, d=0.17). 
Considering age and ICR as continuous variables, ICR was negatively related to age in the low 
AUDIT-c group (r(62)=-0.46, p<0.001, β=-0.034), reflecting a 2.9% decrease in ICR with each 
year of age >18. No such age effect was detected in the high AUDIT-c group (r(107)=-0.033, 
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p=0.37, β=-0.003). Qualitatively similar results were obtained with AUC values (data not 
shown). As in a priori age groups, we found no age effect on response consistency (data not 
shown). 
 
Figure 3.3: Interacting effects of age and alcohol consumption on delay discounting behavior. 
Plot depicts the ratio of immediate reward choices (ICR) in the delay-discounting task as a 
function of post hoc defined AUDIT-c and age groups. There was a significant age by AUDIT 
consumption group interaction on ICR, F(1, 157)=8.32, p=0.004, η
2
=0.047. *ICR is higher in heavy 
(AUDIT consumption ≥5) versus light/moderate drinking adults (t(27)=-2.28, p=0.031, d=-0.88). 
In emerging adults (ages 18-24), ICR does not differ based on alcohol consumption 
(t(115.216)=1.018, p=0.311, d=0.17). AUDIT-c, AUDIT consumption subscale. *p<05. 
 
High ICRs in late adolescents is not driven by underage drinkers 
Both our a priori late adolescent and post hoc emerging adult groups included 
participants under the U.S. legal drinking age (21 yrs), raising the concern that the high ICRs of 
the adolescent/emerging adult groups are driven by underage drinkers. Thus, we tested for a 
relationship between age and ICR within the low and high AUDIT groups after excluding 
participants (n=71) <21. In the low AUDIT (AUDIT<8 Males, <5 Females) group, we still 
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observed a significant negative relationship between ICR and age (r(66)=-0.283, p=0.010; β=-
0.025), reflecting a -2.4% drop in ICR with each year of age >21. Likewise, in the high AUDIT 
group, we still observed no relationship between age and ICR (r(96)=-0.031, p=0.38; β=-0.003). 
Moreover, among low AUDIT individuals, 21-24 year olds had a mean ICR 24.9% higher than 
that of participants >25 yrs (0.67±0.24 vs. 0.46±0.37; t(25.414)=2.36, p=0.026). In addition, among 
21-24 year olds, we found no significant difference in mean ICR between high AUDIT 
(0.62±0.32, n=69) and low AUDIT groups (0.67±0.24, n=44; t(108.566)=1.069, p=0.29), and no 
relationship between AUDIT and ICR (r(111)=0.056, p=0.55). Qualitatively similar effects were 
found using AUDIT-c scores in correlation analyses and group definition (data not shown). 
Thus, Now bias observed here among the late adolescents/emerging adults are not driven by 
current underage drinkers. 
 
Age and Age x AUDIT-c effects are not confounded by college student status 
 Our participants consisted of a large portion of undergraduate and graduate students 
(43.5%) with the proportion of students in our emerging adult (18-24) group (48.4%) 
significantly greater than that in our adult (26-40) age group (28.2%; χ2=5.29, df=1, p=0.021). 
We covaried for student status in our key analyses: the Low vs High AUDIT group x age group 
ANOVA resulted in similar effects to those observed without this covariate (see: Effects of age 
and AUDIT group on ICR, above): a trend toward a main effect of age group (F(1,216)=3.57, 
p=0.06, η2=0.016) and a significant age*AUDIT interaction (F(1,216)=5.08, p=0.025, η
2
=0.022). 
Revisiting our AUDIT-c by age group ANOVA, covarying for student status did not alter our 
results: significant effect of age group (F(1,156)=5.94, p=0.016, η
2
=0.034), AUDIT-c group 
(F(1,156)=4.34, p=0.039, η
2
=0.025), and age*AUDIT-c group interaction (F(1,156)=8.14, p=0.005, 
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η2=0.047) on ICR. Thus differences in the number of students in our age groups cannot explain 
the age and age x AUDIT-c effects we observed on ICR.   
Table 3.7: Demographic, Substance Use Related, and Psychometrics Measures Across Age and 
High/Low AUDIT-c groups 
 Light/Moderate Drinkers 
(AUDIT-c < 4) 
Heavy Drinkers 
(AUDIT-c ≥ 5) 
 
 Ages 18-24 
(n = 44) 
Ages 26-40 
(n = 16) 
Ages 18-24 
(n = 89) 
Ages 26-40 
(n = 13) 
Age*AUDIT-c 
interaction 
      F158 p 
Demographic       
Age (yrs)  20.5 ± 1.8 31.4 ± 3.8 21.1 ± 1.7 32.2 ± 4.3 0.06 0.80 
Education (yrs)  14.5 ± 1.7 17.3 ± 1.3 14.8 ± 1.5 17.5 ± 3.4 0.00
2 
0.97 
SES  47.5 ± 11.6 52.2 ± 7.6 51.6 ± 7.5 51.7 ± 10 1.53 0.22 
Ethnicity (% non-white)  20.5 31.3 30.3 38.5  0.52
†
 
Sex (% female) 59.1 62.5 44.9 62.5  0.26
†
 
COMT genotype               
(% ValVal) 
20.5 18.8 28.1 46.2  0.58
†
 
       
Substance use-related        
AUDIT  2.7 ± 2.2 2.9 ± 2.2 12.6 ± 5.2 8.7 ± 2.7 5.71 0.018 
AUDIT consumption  2.1 ± 0.9 2.2 ± 0.9 7.0 ± 1.6 5.5 ± 0.7 7.62 0.006 
AUDIT D/H  0.8 ± 1.5 0.8 ± 1.8 5.9 ± 4.0 3.2 ± 2.5 4.23 0.041 
RAPI  2.3 ± 3.2 2.1 ± 7.5 12.1 ± 7.7 6.2 ± 4.3 4.59 0.034 
DUSI 0.09 ± 0.11 0.10 ± 0.14 0.39 ± 0.16 0.25 ± 0.20 6.64 0.011 
DAST  0.66 ± 0.83 1.0 ± 1.2 3.0 ± 2.8 2.8 ± 4.1 0.23 0.63 
FTQ density (%) 14.2 ± 16.5 25.9 ± 20.6 15.9 ± 17.3 20.3 ± 23.5 0.95 0.33 
       
Psychometric       
BIS - total  56.1 ± 9.3 55.8 ± 7.6 62.0 ± 9.7 54.5 ± 9.8 3.38 0.068 
      BIS Attention 15.3 ± 3.2 14.3 ± 3.3 16.2 ± 3.7 13.9 ± 3.5 0.69 0.41 
      BIS Motor  20.9 ± 3.7 20.8 ± 2.1 22.7 ± 3.8 19.5 ± 3.6 4.39 0.038 
      BIS Non-Planning 19.9 ± 4.5 20.7 ± 4.4 23.1 ± 4.7 21.1 ± 4.7 2.11 0.149 
FTPI mean ext (yrs) 8.4 ± 5.3 6.0 ± 4.5 8.0 ± 6.1 6.6 ± 5.6 0.16 0.69 
FTPI max ext (yrs) 28.3 ± 19.8 22.2 ± 16.1 30.4 ± 24.3 22.8 ± 15.1 0.03 0.86 
Values are reported as mean ± standard deviation. Reported F and p-values reflect the results testing for significant 
age by AUDIT group interactions. Exact p-values reported unless p < 0.001.  Conventions as per Table 3.1. 
†
p-value 
represents results of χ2 test.  
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Family history of alcoholism and DD 
Our findings thus far do not point to heightened Now bias as a pre-existing trait 
associated with AUD risk, as it was present generally among emerging adults. However, another 
way to identify intermediate phenotypes for complex neurobehavioral disorders is to compare the 
behavior of unaffected people with and without  1° relatives with the disorder (Meyer-
Lindenberg and Weinberger, 2006). As our sample included a significant proportion of FHP 
participants (~23%), we conducted a 3-way ANOVA, with the following factors: post-hoc age 
group, AUDIT-c group, and FH (see Methods). We found a trend toward a main effect of FH on 
ICR with higher ICRs among FHP individuals (0.69±0.24) relative to FHN individuals 
(0.66±0.3; F(1,137)=3.635, p=0.059, η
2
=0.022). We found a significant FH*age interaction 
(F(1,137)=5.333, p=0.022, η
2
=0.033), reflecting a trend toward higher ICRs among FHP adults 
(ages 26-40; 0.65±0.26) relative to FHN adults (0.46±0.37; F(1,31)=3.769, p=0.061, η
2
=0.10), and 
no significant difference in ICR between FHP (0.70±0.23) and FHN (0.69±0.28; F(1,166)=0.424, 
p=0.516, η2=0.003) emerging adults. While, we found no significant FH*AUDIT-c interaction 
(F(1, 137)=0, p=0.995, η
2
=0), we did observe a near-significant 3-way interaction effect on ICR 
(F(1,137)=3.537, p=0.062, η
2
=0.022). This reflects the fact that among emerging adults, we 
observed a significant FH*AUDIT-c group effect on ICR (F(1,116)=5.034, p=0.027, η
2
=0.042) but 
no main effect of either factor (max. F=0.23). Among heavy drinking emerging adults, ICRs 
were not different between FHP individuals (0.75±0.22) relative to FHN individuals (0.65±0.31; 
F(1,78)=1.73, p=0.192). However, in light drinking emerging adults, we observed a trend toward 
higher ICRs in FHN individuals (0.77±0.19) relative to FHP individuals (0.62±0.25; F(1,37)=3.89, 
p=0.056, η2=0.092). In contrast, among adults, we observed significantly higher ICRs in heavy 
versus light drinkers (F(1, 20)=7.23, p=0.014, η
2
=0.20) and in FHP compared to FHN individuals 
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(F(1, 20)=6.40, p=0.020, η
2
=0.177), but no FH*AUDIT-c interaction (F1, 20)=0.46, p=0.51, 
η2=0.013).  
 
Figure 3.4: Family history of alcohol use disorders is associated with greater Now bias in 
light/moderate drinking adults but not emerging adults. Age group and family history interacted 
to affect ICR (F(1,50)=16.40, p<0.001, η
2
=0.203). This interaction reflects dramatically higher 
ICRs among FHP adults relative to FHN adults (*F(1,12)=7.21, p=0.020, η
2
=0.366) and smaller, 
opposing effects of FH among emerging adults (F(1,37)=3.89, p=0.056, η
2
=0.092). 
 
Specifically looking at the effect of FH on ICR among moderate drinkers, stratified by 
age group, we found a trend toward a main effect of FH with higher ICRs in FHP (0.62±0.25) 
relative to FHN (0.50±0.31; F(1,50)=3.521, p=0.066, η
2
=0.044) participants, but we also found a 
significant age*FH interaction (F(1,50)=16.40, p<0.001, η
2
=0.203; Figure 3.4). This interaction 
reflects dramatically higher ICRs among FHP adults (0.61±0.27) relative to FHN adults 
(0.23±0.32; F(1,12)=7.21, p=0.020, η
2
=0.366) and smaller, opposing effects of FH among 
emerging adults, as reported above. In fact, ICR values of light drinking FHP adults are 
quantitatively similar to that seen in heavy drinking adults in this study and in adults with AUDs 
(Mitchell et al., 2005; Boettiger et al., 2007).  
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Removing participants with potential DSM alcohol dependence did not alter our results 
 As mentioned above, post-hoc evaluation of responses in the Rutgers Alcohol Problem 
Index (RAPI) indicated probable alcohol dependence among 43 recruited subjects (~18%), based 
on Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM–IV; (American 
Psychiatric Association, 1994) criteria. To ensure that these individuals were not confounding 
our results, we removed them from our key analyses. The Low vs High AUDIT group x age 
group ANOVA resulted in similar effects to those observed in the larger dataset (see: Effects of 
age and AUDIT group on ICR, above). We observed a main effect of age group (F(1,177)=5.98, 
p=0.015, η2=0.031) and a significant age*AUDIT interaction (F(1,177)=5.27, p=0.023, η
2
=0.028). 
The AUDIT-c group x age group ANOVA (see: Testing for interacting effect of age and alcohol 
use in AUDIT-c groups, above) produced significant age (F(1,126)=6.57, p=0.012, η
2
=0.045). and 
AUDIT-c (F(1,126)=4.80, p=0.03, η
2
=0.033) effects on ICR, as seen with these possibly dependent 
participants included in the analyses. We also still observed a significant age group x AUDIT-c 
group interaction on ICR (F(1,126)=7.79, p=0.006, η
2
=0.054). Investigating our key family history 
x age group ANOVA in the low AUDIT-c group (see: Family history of alcoholism and DD, 
above), we observed a trend toward an effect of family history on ICR (F(1,48)=3.49, p=0.068, 
η2=0.046) and a significant age group x family history interaction on ICR (F(1,48)=15.279, 
p<0.001, η2=0.199). Again, in our adult low AUDIT-c individuals, FH positive individuals 
displayed significantly higher ICRs (0.62±0.29) than those without a family history of AUDs 
(0.23±0.32; F(1,11)=7.12, p=0.022, η
2
=0.378). We also observed a significant effect of family 
history in the opposite direction in our emerging adult group with the family history negative 
individuals displaying significantly higher ICRs (0.76±0.19) than those FHP (0.62±0.25, 
F(1,36)=4.35, p=0.044, η
2
=0.105). The fact that our key findings are observed when removing 
those participants with potential alcohol dependence suggests that these effects are robust and 
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point to high Now bias (ICR) as a potentially useful intermediate phenotype for AUDs as it is 
observed in heavy drinking adult and family history positive light drinking adult individuals not 
meeting DSM-IV alcohol dependence. 
DISCUSSION  
DD across the lifespan 
We hypothesized based on our earlier work (Mitchell et al., 2005; Kelm et al., 2010) and 
previous DD studies (Green, 1994; Scheres et al., 2006; Olson et al., 2007; Eppinger et al., 2012) 
that Now bias would decline in light/moderate drinkers during the transition from emerging 
adulthood to adulthood. Here we demonstrate that DD indeed negatively correlates with age well 
into the second decade of life among moderate FHN drinkers, with reduced Now bias typically 
observed by the mid-twenties. It should be noted that a study by Dom et al (2006) found a 
significant negative relationship between discounting behavior and age in a control, non-problem 
drinking group that was not observed in early or late onset problem drinkers. Thus, there is some 
existing evidence in the literature that age may be related to discounting behavior in non-problem 
drinkers and that problem drinking may uncouple this relationship. Our findings lend further 
support for this hypothesis and warrant further investigation. If emerging adults (18-24) tend to 
show heightened Now bias, the utility of this behavior as an intermediate phenotype may be 
restricted to older individuals. 
 
DD and alcohol use   
Investigators consistently find greater Now bias in participants with AUDs versus those 
without (Petry, 2001; Bjork et al., 2004; Mitchell et al., 2005; Boettiger et al., 2007; Mitchell et al., 
2007), and greater DD among heavy versus lighter social drinkers was reported in a small college 
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age sample (Vuchinich and Simpson, 1998). A recent meta analysis of DD behavior across 
addictions (MacKillop et al., 2011) reported modest effects of subclinical heavy alcohol use on 
increased discounting behavior. Other than the Vuchinich and Simpson (1998) study, all remaining 
subclinical findings reported in that meta analysis consisted of questionnaire-type measures of 
discounting behavior, which could be less reliable than behavioral-based methods to assess 
discounting. Thus, our study focused on subclinical problematic drinking behavior in a relatively 
large sample to address the limited information we have on behavioral discounting in problematic 
drinkers not identifying themselves as having an alcohol use disorder. Here, we observed greater 
DD with heavy alcohol use specifically among adults (>25 yrs) but not emerging adults (18-24). It 
should be noted that Vuchinich and Simpson (1998) was a relatively small study (n=31) using 
different problem drinking determination and DD measures than those used here. Also, nearly all 
of Vuchinich and Simpson’s problem drinkers were under age 20 while the social drinking group’s 
average age >20. Thus, if age is negatively related to DD in general, as we propose in this study, 
the drinking status effects observed in Vuchinich and Simpson could have been confounded by age 
differences across their groups. Further investigation of the interaction of age and problem alcohol 
use on discounting behavior is warranted to resolve our findings with Vuchinich and Simpson 
(1998). 
While previous studies that included participants with AUDs found ICR to positively 
correlate with AUDIT dependence and harm subscales (Mitchell et al., 2005), but not AUDIT-c; in 
this larger sample of participants self reporting no drinking problems, AUDIT-c  score best 
predicted ICR. Taking an AUDIT-c cutoff score of 5, which fairly specifically identifies heavy 
drinkers (Bush et al., 1998), we found substantially greater Now bias among heavy drinking 
adults relative to lighter drinking adults, with the ICR’s of heavy drinking adults on par with 
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those of adults with AUDs (Mitchell et al., 2005; Boettiger et al., 2007). Thus, heightened Now 
bias in adults may be an early indicator of AUD risk. Among emerging adults, in contrast, our 
findings suggest that developmental effects on DD behavior generally occlude a relationship 
between alcohol use and ICR, except in FHP individuals. In that particular at-risk population, 
heightened Now bias is associated with heavy, sub-clinical alcohol use, and may have practical 
utility in identifying at-risk individuals. Future longitudinal studies are required to further 
investigate this issue. 
Impulsivity in emerging adults & heavy drinking adults: shared mechanisms? 
Our data demonstrates equivalent DD between two groups at risk for developing AUDs: 
emerging adults and heavy drinking adults. The fact that heavy drinking emerging adults did not 
show higher ICRs than moderate drinking emerging adults suggests the possibility of shared 
underlying mechanisms in these populations. For example, both groups might have dysfunction 
in the frontal circuitry engaged during Now/Later decision-making (Boettiger et al., 2007). A 
variety of evidence indicates that frontal development is incomplete until the early-to-mid twenties 
(Sowell et al., 1999; Casey et al., 2000; Sowell et al., 2001; Giedd, 2004; Gogtay et al., 2004; 
Lenroot and Giedd, 2006), and functional maturation of brain circuits begins to plateau at ~22 
yrs, with continuing maturation into the mid-to-late twenties (Dosenbach et al., 2010). Such 
maturational effects are consistent with our finding that “adult-like” DD emerges sometime 
between ages 22-26. Indeed, a structural neuroimaging study of individuals aged 9-23, showed that 
age-related increases in frontal white matter integrity negatively correlate with Now bias (Olson et 
al., 2009); however, that study included very few individuals >18, precluding conclusions 
regarding changes from late adolescence to early adulthood. Recent functional neuroimaging data 
show that DD decreases from early adolescence (age 11) to early adulthood (age 31) are 
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associated with changes in corticostriatal circuit function (Christakou et al., 2011). Thus, 
structural and functional changes in frontal circuits could underlie the age-related decline in DD 
we observed among moderate FHN drinkers. Not only do frontal circuits mature late, they are 
especially prone to insult by heavy alcohol consumption, especially binge drinking (De Bellis et 
al., 2005; Miguel-Hidalgo et al., 2006; Jacobus et al., 2009; McQueeny et al., 2009), and decreased  
frontal metabolism is observed in AUDs (Volkow et al., 1997; Catafau et al., 1999). Thus, we 
speculate that Now bias reflects immature frontal function in emerging adults, and dysfunction in 
similar circuits in heavy drinking adults. 
 
Now bias as an AUD intermediate phenotype  
Determining the biological basis of risk for complex neurobehavioral disorders like 
AUDs is difficult due to multiple interacting risk factors. Moreover, genes do not encode for 
psychopathology, hence the association of gene effects should be greater at the level of simpler, 
intermediate phenotypes (Meyer-Lindenberg and Weinberger, 2006). We argue that Now bias in 
adults shows promise as an intermediate phenotype for AUDs, as has been recently suggested of 
discounting behavior by others (MacKillop, 2013). First, Now bias is obviously related to AUDs, 
as every relapse or excess drink represents a decision favoring immediate over delayed benefits. 
Second, DD behavior has good psychometric properties; as we demonstrate here, responses are 
highly reliable (Chronbach’s α >.98). Third, DD behavior is stable over time (Kirby, 2009). 
Fourth, as we show here, Now bias occurs to a greater degree in unaffected relatives. Fifth, DD 
behavior is heritable and associates with substance use, suggesting common genetic influences 
with SUDs (Anokhin et al., 2011). Evidence regarding cosegregation of Now bias with AUDs 
within families is currently lacking, but every other criteria appears to be met (Meyer-
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Lindenberg and Weinberger, 2006; MacKillop, 2013). Other factors may impact DD in 
adolescence, obscuring the utility of this behavioral intermediate phenotype in late 
adolescents/emerging adults, however, future neuroimaging studies may identify a neural 
signature associated with Now bias that is enhanced in FHP adolescents.  
 
Family history of AUDs and Now bias 
With regards to earlier studies investigating the effect of family history status on 
discounting behavior, it is worth noting that most of the studies focused on individuals under the 
age of 26 (Crean et al., 2002; Herting et al., 2010) found very modest to no effect of family 
history status on discounting behavior. A study by Petry et al. (2002) which found effects of 
family history on discounting in females had an average age around 26, thus, this study 
potentially contained enough adult participants (using the definition of 26-40 proposed in our 
current study) to observe an effect of family history. The fact that Petry et al. observed family 
history effects in females only (Petry et al., 2002) supports the idea that developmental 
“maturity” may be needed to see family history effects. Female brains are believed to reach 
functional maturity a few years earlier than males (Lenroot et al., 2007; Lenroot and Giedd, 
2010). Thus, Petry et al.’s female participants may have been mature enough for FH effects to be 
observed while the effect in males could have been obscured by the fact that their brains could 
have still been developing during the early-to-mid twenty age range of participants sampled in 
Petry et al. (2002). In the current study, we observed a family history effect when focusing on 
26-40 year old light/moderate drinkers. Thus, otherwise non-affected adults (light/moderate 
drinking; no reported AUDs) with at least one first degree relative with an AUD show 
heightened Now bias relative to those without a family history of AUDs, a critical demonstration 
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of heightened Now bias as an intermediate phenotype of AUDs (Meyer-Lindenberg and 
Weinberger, 2006). We believe our findings here point to the importance of considering how age 
effects may occlude the identification of factors such as family history on delay discounting 
behavior. Future studies should explore the effect of family history on discounting behavior in 
adult samples to confirm our findings that Now bias meets this important intermediate phenotype 
criteria.  
 
Study limitations 
First, while our recruitment group age ranges were evidence-based and yielded a main 
effect of age group on ICR in moderate drinkers, our data indicate that ICR decreases 
substantially with age until ~26 yrs. Our sample size in the 26-40 group limited our power to 
investigate effects of other factors on ICR (e.g. sex) in adults. Second, we sought to investigate 
ICR in groups at risk for AUDs, thus excluding individuals with AUDs, however, we did not 
conduct clinical interviews to directly establish AUD diagnoses. Third, our measure of alcohol 
consumption, the AUDIT-c score, has the limitations of any self-report measure and is a coarse 
measure of alcohol use. More detailed measures of drinking behavior will be needed to 
determine how the quantity, frequency, and pattern of alcohol consumption may relate to ICR. 
For example, binge drinking may be a stronger predictor of ICR, as it is most damaging to the 
brain and frontal cortices in particular.    
Our results are suggestive that Now bias decreases with age in light/moderate but not 
heavy, problem drinkers. The cross-sectional nature of this study, however, prevents us from 
being able to directly test whether Now bias relates to aging within individuals differentially 
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based on their drinking behavior. Longitudinal studies are needed to directly confirm our 
hypotheses.   
Conclusions  
Here, we found that three AUD risk factors strongly predict Now bias: age, heavy alcohol 
use, and FH status. We show that Now bias declines with age in FHN moderate drinkers, with 
ICR declining to adult levels around the mid-twenties. In adults, we also found that either heavy 
alcohol use or a positive FH for alcoholism is associated with Now bias equivalent to that seen in 
abstinent alcoholics. Thus, Now bias may be an intermediate phenotype common to groups at 
higher risk for AUDs that is present before an AUD. While the underlying neural mechanisms of 
elevated ICR in emerging adults, heavy drinking adults, and FHP individuals remains to be 
investigated, Now  bias represents a promising intermediate phenotype for AUD risk. As such, 
modification of this behavior may prove an effective AUD prevention strategy in at-risk groups. 
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CHAPTER 4: OVARIAN CYCLE EFFECTS ON IMMEDIATE REWARD BIAS IN 
HUMANS: A ROLE FOR ESTRADIOL 
 
INTRODUCTION  
All animals, including humans, discount  delayed rewards (Mazur, 1987; Rachlin, 2000), 
a tendency variously known as delay discounting (DD), temporal discounting, or immediate 
reward bias. While some degree of DD is normal, excessive immediate reward, or ”Now”, bias 
is associated with multiple clinical conditions, including substance abuse (Becker and Murphy, 
1988; Reynolds, 2006; Perry and Carroll, 2008; Rogers et al., 2010), attention deficit 
hyperactivity disorder (Barkley et al., 2001; Sonuga-Barke et al., 2008; Paloyelis et al., 2010), 
pathological gambling (Alessi and Petry, 2003; Leeman and Potenza, 2012), and obesity (Weller 
et al., 2008; Epstein et al., 2010). Thus, understanding the biological bases of such Now bias may 
have wide-reaching impact. Evidence from both humans and animals indicates that individual 
DD tendency is highly heritable (Anokhin et al., 2011; Mitchell, 2011). However, animal studies 
also indicate that Now bias can be pharmacologically modulated, particularly by dopamine (DA) 
(Dalley et al., 2008; Doya, 2008; Winstanley, 2011). 
Accumulating work in humans also suggests DA as a key regulator of Now bias. First, 
genetic variations in the DA system are associated with individual differences in Now bias 
(Boettiger et al., 2007; Eisenberg et al., 2007; Paloyelis et al., 2010; Smith and Boettiger, 2012), 
particularly variations in the gene encoding the catechol-O-methyltransferase (COMT) enzyme, 
which regulates tonic frontal DA (Karoum et al., 1994; Gogos et al., 1998; Slifstein et al., 2008; 
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Kaenmaki et al., 2010; Wu et al., 2012); putative lower tonic frontal DA is associated with 
greater Now bias among adults (Boettiger et al., 2007; Smith and Boettiger, 2012). Second, 
human pharmacology studies suggest that DA modulates Now bias, albeit with inconsistent 
results (de Wit et al., 2002; Acheson and de Wit, 2008; Hamidovic et al., 2008; de Wit, 2009; 
Pine et al., 2010), although these studies have not accounted for intrinsic variations in DA 
signaling that could interact with pharmacological effects. For example, we recently found that 
genetic variation in COMT modulates the effect of an acute DA manipulation on Now bias (Kelm 
and Boettiger, 2013). Recent data showing that COMT genotype interacts with cyclic estradiol 
(E+) changes to affect working memory (Jacobs and D'Esposito, 2011), which is also frontal 
DA-dependent, suggests that cyclic variation in E+ could also modulate Now bias. 
Data showing less DD among females relative to males (Bobova et al., 2009; Peper et al., 
2013) supports this idea, but no studies have investigated whether cyclic E+ fluctuations are 
associated with changes in Now bias. We hypothesized that if E+ modulates Now bias, naturally 
cycling females should demonstrate reduced Now bias from the menstrual phase (MP) to the 
follicular phase (FP).  Moreover, such cycle effects should be modulated by COMT genotype. To 
test these ideas, we measured Now bias in a DD task among naturally cycling females (ages 18-
40), during both the MP (cycle day 1-2; putative low E+), and the FP (cycle day 11-12; putative 
high E+). We also determined COMT genotype for each subject, and were able to measure free 
salivary E+ in each visit from a subset of participants.  
METHODS 
Sample Characteristics 
Participants (n=91) were recruited from the University of North Carolina, Chapel Hill 
(UNC) and surrounding community. Participants were healthy females 18-40 years old reporting 
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no use of hormonal birth control and regular menstrual cycles of approximately 28 days. 
Participants also had no known past or present neurological or psychiatric diagnoses, no history 
of substance use disorders, and no current use of psychoactive medications or other psychoactive 
substances aside from moderate caffeine, nicotine or alcohol. All subjects were native English 
speakers and had at least a high-school education. Participants gave written informed consent, as 
approved by the UNC Office of Human Research Ethics. Subjects participated in two sessions, 
one on cycle days 1-2 (menstrual phase, MP) and another on cycle days 11-12 (follicular phase, 
FP), in a counterbalanced, within subject design. In addition to the behavioral testing (see “Delay 
Discounting Task”), during session 1 (n=45 MP, n=46 FP), we collected information on 
participants’ age, years of education, trait impulsiveness (Barratt Impulsiveness Scale-11 (BIS) 
(Patton et al., 1995)), orientation toward the future (Future Time Perspective Inventory; FTPI 
(Wallace, 1956)), and locus of control (Rotter’s Locus of Control Scale; LOC (Rotter, 1966)).  
 
COMT Genotyping  
COMT Val
158
Met (rs4680) genotyping was performed on DNA extracted from saliva 
samples (DNA Genotek, Kanata, Ontario, Canada) using TaqMan technology (Life 
Technologies, Foster City, CA), as previously described (Boettiger et al., 2007; Smith and 
Boettiger, 2012). 
 
Delay Discounting Task 
During each testing session, participants completed a delay discounting (DD) task 
described in detail previously (Altamirano et al., 2011; Smith and Boettiger, 2012). Subjects 
were given task instructions, completed a short practice, and then completed 8 blocks of 42 trials 
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each during each test session. In each session, subjects made a series of choices between smaller, 
sooner (“Now”) and larger, later (“Later”) hypothetical monetary rewards. Each trial began with 
an instruction cue, followed by two options. In each trial, the Later option was one of five 
amounts ($2, $5, $10, $20, or $100) at one of five future delays (1 week, 2 weeks, 1 month, 3 
months, or 6 months), and the Now option was an amount discounted by 70, 85, 90, or 95% from 
the Later amount, available “TODAY”. The instruction cue was determined by trial type. There 
were four trial types:  WANT, DON’T WANT, SOONER, and LARGER; the latter two 
conditions are considered together as control (CON) trials. Trial types were pseudorandomly 
ordered and weighted, with 50% W trials, and 16.7% each of the other trial types. Participants 
indicated their preferred option on WANT trials, their non-preferred option on the DON”T 
WANT trials, and the side with the sooner time or larger amount of money for SOONER and 
LARGER (CON) trials, respectively. The Later amount, delay time, percent discount, and 
left/right position were pseudorandomly selected for each trial. The reaction time (RT) for each 
response was also collected. Four subjects failed to follow task instructions, based on faster RTs 
in the WANT and/or DON’T WANT trials than in the CON trials for one or more sessions, and 
were excluded from all analyses, leaving n=87 participants. Of these, n=44 were first tested in 
the MP, and n=43 were first tested in the FP.  
Our primary index of Now bias was the proportion of Now choices made in the WANT 
condition, the impulsive choice ratio (ICR). From our DON’T WANT trials, we determined the 
inferred ICR (iICR) as a function of delay time and calculated the average of the absolute value 
of the difference between ICR and iICR at each delay. This value provides a measure of response 
consistency, termed motor mismatch, with larger values indicating less controlled response 
 67 
 
selection (Mitchell et al., 2007). Change in ICR from the MP to FP was calculated as a simple 
subtraction of the ICR in the FP session from ICR in the MP session.  
 
Salivary Estradiol Quantification  
Multiple saliva samples (3 collections over ~1 hour) were collected during each session 
from a subset of participants (n=34)  via passive drool into 15mL tubes over a period of ~1 hour 
while they completed questionnaires and/or during task breaks. Samples were pooled and stored 
at -20°C until analysis. Upon thawing, saliva samples were centrifuged at 1500 × g for 15 
minutes to separate mucous material and pellet out any potential contaminants. Cleared saliva 
was then decanted into a separate tube. We quantified salivary estradiol via an enzyme 
immunoassay kit (Salimetrics, State College, PA, USA). On each plate, pooled samples were 
tested in duplicate, with samples from both visits for each subject tested on the same plate. 
Optical densities were measured using a μQuant microplate spectrophotometer (BioTek, 
Winooski, VT), and, following kit procedure, were transformed into pg/ml E+ values based on 
plate-specific 4-parameter sigmoid minus curves derived from standard E+ samples. E+ 
concentrations for each sample were averaged across plates. Only individuals with higher 
average E+ in their FP sample than in their MP sample were classified as showing a positive 
change in E+ (∆E+). The proportional change in E+ value used in our correlation analyses reflect 
the difference in E+ between the FP and MP samples divided by MP E+ (ΔE+=(FP E+ – MP E+)/ 
MP
 E+
). 
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Statistical Analysis 
 As ICR data in this sample was not normally distributed (D(174)=0.12, p<0.001; 
Kolmogorov-Smirnov test), the Wilcoxon sign-ranked test was used for comparison of ICR 
across sessions. Paired t-tests and repeated measures ANOVAs were used to test for the effect of 
Cycle Phase on other DD task measures as well as on arc-sine root transformed ICR values. 
Group comparisons of ICR change were made using unpaired t-tests. Pearson’s r or Spearman’s 
Rho ρ were used for correlation analyses, as indicated. 
 
RESULTS  
Sample characteristics 
 Eighty-seven healthy females from the Chapel Hill/Durham area volunteered and were 
paid for their participation (Table 4.1). In the sample as a whole, we observed a positive 
correlation (r(85)=0.22, p=0.040) between Now bias measured in session 1 and the non-planning 
subscale of the Barratt Impulsiveness Scale (BIS), a trait measure of impulsivity, which is 
consistent with some previous findings (Mitchell et al., 2005; de Wit et al., 2007).  
  
Impulsive choice declines from early to mid-cycle 
 We predicted a decline in our measure of Now bias, the impulsive choice ratio (ICR; see 
Methods) from the MP to the FP, which was indeed observed. Across all participants, we found a 
significant effect of cycle phase on ICR with higher ICRs in the MP (Median=0.72) relative to 
the FP (Median=0.66) using either a Wilcoxon signed-rank test on the raw ICR values (z=-2.77, 
p=0.006, r=-0.21), or a paired samples t-test on arc-sine root transformed ICR data (t86=2.13, 
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p=0.036; Fig. 4.1). Although we counter-balanced session order, we confirmed that this cycle 
effect remained significant after covarying for session order in a repeated measures ANOVA 
(F(1,85)=4.65, p=0.034, η
2
=0.049).  
Table 4.1: Demographic data overall and by first session cycle phase. 
 Demographics Across All Participants and Broken 
Down by First Session Cycle Phase  
 All (n = 87) MP (n=44) FP (n=43) 
Age (yrs) 24 ± 5   
Education (yrs) 16 ± 2   
Psychometric Measures    
       BIS Total Score 60.2 ± 11.7 60.6 ± 11.6 59.8 ± 12.0 
     BIS Attention 16.4 ± 4.1 16.6 ± 4.1 16.3 ± 4.2 
     BIS Motor 21.6 ± 4.2 22.0 ± 3.9 21.3 ± 4.6 
     BIS Planning 22.2 ± 5.4 22.1 ± 5.4 22.3 ± 5.5 
       FTPI    
           Mean extension 6.9 ± 5.2 7.2 ± 6.0 6.7 ± 4.3 
           Max extension 23.7 ± 18.2 25.6 ± 20.7 21.7 ± 15.3 
       LOC        11.0 ± 4.0 11.1 ± 4.6 11.0 ± 3.3 
    
Genetics           
     COMT Val
158
Met genotype (%)    
     Met/Met (%) 19.5   
     Met/Val (%) 44.8   
     Val/Val (%) 35.6   
Demographic data. Values are reported as mean ± standard deviation. BIS, Barratt Impulsiveness 
Scale; FTPI, Future Time Perspective Inventory; LOC, Rotter’s Locus of Control Scale; MP, 
Menstrual Phase; FP, Follicular Phase  
 
This Now/Later task includes objective choice control (CON) trials; accuracy in these 
trials did not differ significantly between the MP and FP sessions (t86=-0.66, p=0.51). The task 
also includes a control condition (DON’T WANT) in which participants are instructed to select 
the monetary reward option that they do not prefer. Comparing ICR in the WANT trials to 
inferred ICR in the DON’T WANT trials provides a measure of response consistency. We 
observed significant effect of cycle on response consistency, or motor mismatch (see Methods), 
with greater mismatch in the FP (0.13±0.08) relative to the MP (0.10±0.06; t86=-2.63, p=0.010). 
Importantly, our observed cycle effect on Now bias remained significant after covarying for 
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changes in response consistency in a repeated measures ANOVA (F(1,85)=6.02, p=0.016, 
η2=0.066), indicating that a drop in response consistency cannot explain the decrease in Now bias 
at mid-cycle. We observed no cycle effects on reaction time (RT) in the objective choice (CON) 
trials (t86=1.28, p=0.21), subjective choice (WANT) (t86=-0.01, p=0.99), or DON’T WANT 
(t86=-0.27, p=0.79) trials. 
 
Figure 4.1:  Immediate reward (Now) bias declines from early to mid-cycle. Plot depicts an 
index of Now bias, the impulsive choice ratio (ICR), measured during the menstrual phase (MP; 
cycle day 1-2) and follicular phase (FP; cycle day 11-12), within subjects. ICR’s were 
significantly reduced at mid-cycle (FP) relative to the MP (*t86=2.13, p=0.036). Values reflect 
mean ± SEM ICR. 
 
 The mid-cycle-drop in Now bias is associated with an E+ rise 
 While the decrease in Now bias from the MP to the FP is consistent with a hypothetically 
E+-mediated effect, hormonal variation across the cycle varies, even among women with regular 
cycles. To more directly assess the relationship between changes in E+ and changes in Now bias, 
we assayed salivary E+ from both sessions from a subset of participants (n=34). On average, E+ 
rose (0.50±0.23 pg/mL) from the MP to the FP (t(33)=-2.20, p=0.035).  However, of the 34, only 
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23 participants demonstrated a detectable increase in E+ from the MP to the FP (E+ rose 1.15 ± 
0.89 pg/ml, t(22)=-6.20, p<0.001; critically, these 23 participants also showed a significant 
decrease in Now bias (-0.07±0.03) from the MP to the FP (t(22)=-2.18, p=0.041; Fig. 4.2). In 
contrast, in those without a detectable rise in E+ (n=11; E+ decreased by 0.85±1.07 pg/ml; 
t(10)=2.62, p=0.026) Now bias tended to rise from the MP to FP (0.05±0.05; t(10)=1.09, p=0.303; 
Fig. 4.2). The cycle-effect on Now bias differed significantly between the E+ rise and the no E+ 
rise participants (t32=2.145, p=0.040; Fig. 4.2).  
 
Figure 4.2:  Now bias declines at mid-cycle when estradiol (E+) rises at mid cycle. Plot depicts 
change in ICR from early to mid-cycle in participants with a verified rise in E+ at mid cycle (E+ 
rise), and those without a detectable rise in E+ at mid-cycle (No E+ rise). ICR declines 
significantly at mid-cycle in the E+ rise group (
†
t22=-2.18, p=0.041). The change in ICR from 
early to mid-cycle differed significantly between the E+ rise & no E+ rise groups (*t32=2.145, 
p=0.040).  
 
Changes in Now bias from the MP to FP are inversely related to changes in E+ 
As we observed substantial variation in E+ changes from the MP to the FP, we tested 
whether the magnitude of E+ change between sessions was correlated with individual change in 
Now bias. To avoid concerns about violating parametric assumptions, we calculated the 
Spearman’s rho (ρ) between the proportional change in E+ from the MP to the FP and ICR 
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change from the MP to the FP and conducted a robust regression analysis procedure using 
bootstrapping. We found a significant negative correlation between E+ change and ICR change 
(ρ(32)=-0.39; 95% CI: -0.67, -0.06, p=0.023; Fig. 4.3, solid line), suggesting a role for E+ in 
mediating the observed cycle effects on Now bias.  
 
Figure 4.3:  Change in ICR from early to mid-cycle is proportional to the change in E+ and 
driven by low putatively lower tonic frontal dopamine COMT
Val 
carriers. In the sample as a 
whole, ICR decreases correlate with E+ increases (ρ=-0.39, p=0.023, solid line). This effect is 
driven by COMT
Val
 allele carriers (open circles; ρ=-0.58, p=0.003, dotted line). Changes in E+ 
and ICR from MP to FP are not correlated in individuals with putatively high tonic frontal 
dopamine (COMT
Met/Met
 (filled circles), ρ=0.12, p=0.75, dashed line).  
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E+ in session 1 correlates with trait impulsivity 
Based on our findings that session 1 ICR positively correlated with BIS non-planning 
scores, and that ICR fluctuated from the MP to the FP in tandem with E+ changes, we tested 
whether E+ levels in session 1 correlated with BIS non-planning scores. We found that indeed 
each additional pg/ml of E+ measured in session 1 was associated with 0.79 points lower BIS 
non-planning scores (r(32)=-0.42, 95% CI: -0.63, -0.20, p=0.014). A similar relationship between 
session 1 E+ levels and total BIS scores (r(32)=-0.36, p=0.036) was also observed.  
 
COMT genotype modulates E+ effects on Now bias 
 As the effects of E+ changes from the MP to FP on working memory, which is also 
frontal DA-dependent, are modulated by COMT Val
158
Met genotype (Jacobs and D'Esposito, 
2011), we tested whether the observed relationship between E+ elevation and reduced Now bias 
is also modulated by COMT genotype. Of the participants from whom we had E+ measures, the 
distribution of COMT genotypes was: 10 Met/Met, 9 Met/Val, 15 Val/Val.  Unlike the full 
sample, within the Met/Met group, we observed a statistically insignificant increase in ICR with 
greater E+ rises (ρ(8)=0.12, p=0.75; 95% CI: -0.68, 0.70; Fig. 3, dashed line). However, in the 
Met/Val group, we observed a trend toward greater mid-cycle declines in ICR with greater E+ 
rises (ρ(7)=-0.63, p=0.067; 95% CI: -1.0, 0.24); Val homozygotes showed a similar negative 
relationship (ρ(13)=-0.29, p=0.302; 95% CI: -0.73, 0.34). Based on this similarity between the 
latter two groups, we considered Val allele carriers together and found significantly greater 
midcycle declines in ICR with greater midcycle E+ rises among Val carriers (ρ(22)=-0.58, 
p=0.003; 95% CI: -0.78, -0.22; Fig. 3, dotted line), indicating that Val carriers drove the effect 
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observed in the sample as whole. Note that average E+ in the MP (F(2,31)=0.91, p=0.412) and FP 
(F(2,31)=0.05, p=0.952) visits did not differ significantly by COMT genotype. However, there was 
a trend toward COMT genotype-dependent effects on the difference in measured E+ between the 
MP and FP visits (F(2,31)=3.05, p=0.062), reflecting the fact that we observed the greatest rise in 
E+ among COMT
Met/Met
 individuals (0.78±0.91, standardized values), with substantially smaller 
average E+ rises in COMT
Val/Met
 (0.31±0.41) and COMT
Val/Val
 (0.18±0.47) individuals. The 
difference in E+ rise between the COMT
Met/Met
 and COMT
Val/Val
 groups approached statistical 
significance (t(12.28)=-1.97, p=0.072). Thus, the apparently greater sensitivity of Now bias to 
changes in E+ among COMT
Val 
carriers cannot be attributed to differences in baseline E+ levels 
or to a greater degree of E+ change among the COMT
Val 
carriers, who together had smaller 
increases in E+ from the MP to the FP than COMT
Met/Met
 individuals (0.22±0.45; t(10.86)=1.87, 
p=0.088).  
 Based on our previous observation in a mixed sample of males and females that age 
interacts with COMT genotype to predict Now bias (Smith and Boettiger, 2012), we also 
conducted an exploratory examination of the correlation between E+ change and ICR change 
within COMT Val carriers separately within our previously defined age groups (ages 18-21 vs. 
22-40). We observed a substantially larger correlation among 22-40 year old COMT
Val
 carriers 
(ρ(9)=-0.77, p=0.005; 95% CI: -0.95,-0.26), who, according to our inverted-U model (Smith and 
Boettiger, 2012), should have the lowest tonic PFC DA, relative to 18-21 year old Val carriers 
(ρ(11)=-0.604, p=0.029; 95% CI: -0.93, -0.09). Within the group with the highest predicted tonic 
PFC DA (18-21 year old Met/Met individuals), increasing E+ was associated with increased ICR 
at mid-cycle; although the effect was not statistically significant (ρ(2)=0.400, p=0.60). The 
relationship between E+ change and ICR change was relatively flat in 22-40 year old Met/Met 
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group (ρ(4)=-0.086, p=0.872). While these observations are consistent with our hypothesized 
results, these are highly preliminary findings, and it is particularly important to note that the tests 
within the Met/Met age groups are grossly underpowered to detect even large effects. 
 
DISCUSSION 
Here, we demonstrate that Now bias decreases significantly from the MP to the FP. 
Participants with a verified rise in E+ from the MP to the FP visit showed significantly greater 
decreases in Now bias at midcycle than those without, with Now bias decreasing significantly in 
the E+ rise group but not in the no E+ rise group. The change in Now bias from the MP to the FP 
inversely correlated with the change in E+, and this effect was driven by individuals with 
putatively lower frontal DA based on COMT genotype. These data suggest that the rise in E+ 
during the peak fertility window modulates Now bias through interactions with tonic frontal DA.  
 
Role of Estrogen in Frontal Function 
Existing data link E+ and frontal-dependent function in animals, presumably via E+-
induced enhancement of DA signaling  (Xiao and Becker, 1994; Pasqualini et al., 1995; Shansky 
et al., 2004). E+ increases frontal dopaminergic innervation in primates (Kritzer and Kohama, 
1999),  increases spine number on frontal pyramidal cells (Tang et al., 2004), and affects frontal-
dependent task performance (Tinkler and Voytko, 2005; Hao et al., 2007). Direct evidence for 
the relationship between E+ and frontal DA in humans are lacking, although PET studies suggest 
sex-specific differences in DA D2 receptor levels (Kaasinen et al., 2001) and in amphetamine-
induced DA release in the brain (Riccardi et al., 2006; Riccardi et al., 2011), including frontal 
effects, although, no published studies comparing the sexes have used radiotracers suited to 
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detect frontal D2 binding. Furthermore, there is no published human PET data regarding the 
effect of cyclic E+ changes on DA signaling. However, behavioral and fMRI data from humans 
indicate that E+ modulates frontal-dependent cognitive processes (Keenan et al., 2001), 
including working memory span (Rosenberg and Park, 2002), inhibitory control (Colzato et al., 
2010), and n-back task performance (Jacobs and D'Esposito, 2011; Joseph et al., 2012). In the 
case of n-back performance, E+ effects interact with frontal DA tone, as indexed by COMT 
genotype (Jacobs and D'Esposito, 2011). Given evidence of heightened responses to affective 
stimuli in brain regions linked to arousal during low E+ points in the menstrual cycle (Goldstein 
et al., 2005), the heightened Now bias we observed in the MP could theoretically reflect both 
heightened responsiveness to more proximate rewards and a decrement in frontal function when 
E+ is low. 
 
Dopamine as a potential mediator of the cycle effect on decision-making 
The present data support the idea that E+ modulates Now bias via the DA system, 
especially frontal DA. This conclusion derives from the data described in the previous section 
coupled with our finding that the correlation between E+ changes and Now bias changes from the 
MP to the FP varies with COMT Val
158
Met genotype. The Val158Met polymorphism substitutes 
the ancestral valine (Val) for a methionine (Met) at position 158 in the COMT enzyme, resulting 
in 4-fold reduced enzyme activity (Chen et al., 2004). Reduced tonic frontal DA is observed in 
people with the COMT 158
Val/Val
 genotype relative to COMT
Met
 allele carriers (Wu et al., 2012). 
According to a model wherein Now bias varies with frontal DA according to an inverted-U 
function (Altamirano et al., 2011; Smith and Boettiger, 2012; Kelm and Boettiger, 2013), these 
data suggest that E+ elevations alter Now bias via interaction with frontal DA levels. This idea 
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remains to be empirically tested, but frontal-dependent tasks are generally sensitive to frontal DA 
according to a quadratic function (Sawaguchi and Goldman-Rakic, 1991; Vijayraghavan et al., 
2007; Cools and D'Esposito, 2011).  
 
Role of Other Hormones in Decision Making 
Other steroid hormones are implicated in the modulation of Now bias. For example, 
salivary testosterone correlates with DD among healthy male students (Takahashi et al., 2006). 
Cortisol is also implicated in DD behavior, based on the initial finding that salivary cortisol 
negatively correlates with Now bias (Takahashi, 2004). However, a later study by the same group 
found that sex moderates the effect of salivary cortisol on Now bias, with a negative relationship 
among males, and a positive relationship among females (Takahashi et al., 2010). It is worth 
noting that stress (associated with elevated cortisol) impacts frontal function in an inverted-U 
manner (Arnsten, 2009) and that E+ exacerbates stress-induced working memory impairment in 
animal models (Shansky et al., 2004; Shansky et al., 2009). To date, no studies have investigated 
progesterone effects on DD. Moreover, no study has yet examined multiple steroids, and this 
study is the first to control for cycle phase in females. Future work investigating the individual 
contributions of different steroid hormones is needed for a complete picture of the hormonal 
modulation of Now bias. Perhaps most importantly, to date, no hormone challenge studies have 
been conducted, which are required to determine causal roles in modulating Now bias.  
 
Other potential mediators of the cycle effect on decision-making 
Although our finding of COMT-dependent E+ effects on Now bias suggests a role for DA 
in mediating the observed cycle effect on Now bias, other neurotransmitter systems may also be 
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involved. In particular, progesterone (PROG) or its neuroactive steroid (NAS) derivatives, such 
as allopregnanolone (ALLO), which also rise across the cycle, may contribute. Moreover, ALLO 
appears to modulate cognitive function in humans (Marx et al., 2009), possibly through its 
positive modulation of GABAA receptors (Majewska et al., 1986). Neuroimaging studies have 
demonstrated that PROG increases and E+ decreases from FP to the luteal phase (LP) result in 
changes in activity in a host of PFC, limbic, and striatal regions (Dreher et al., 2007; van Wingen 
et al., 2008; Ossewaarde et al., 2011; Mareckova et al., 2012). Like PROG and ALLO, GABA 
levels also rise from the FP to LP (Epperson et al., 2002). Thus, PROG, ALLO, or GABA may 
alter the function of neural circuitry implicated in Now bias and requires further study. 
Imprecision in our sampling method means that we cannot rule out a role for cyclic changes in 
PROG, ALLO, or GABA in reducing Now bias at mid-cycle. Increased GABAergic signaling 
could theoretically improve cognitive control, leading to reduced Now bias. Indeed, PROG 
administration can improve cognitive control and reduce smoking urges (Sofuoglu et al., 2011). 
However, in women, ALLO impairs episodic memory (Kask et al., 2008), which shares common 
neural substrates with episodic prospection, a mental action that decreases Now bias via 
increased connectivity between the medial temporal lobe, amygdala, and dorsal anterior 
cingulate (Peters and Buchel, 2010; Benoit et al., 2011), a functional connection weakened by 
increases in PROG (van Wingen et al., 2008). Perhaps most pertinent, enhancing GABAA 
signaling reportedly has no effect on Now bias (Reynolds et al., 2004; Acheson et al., 2006). 
Thus, although the reduced Now bias we observed at mid-cycle could theoretically reflect some 
contribution of PROG, ALLO or other NAS, or GABA, no direct data are available, and the 
circumstantial evidence does not favor that interpretation. 
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Study Limitations  
Some limitations of the current study hinder our ability to draw strong conclusions 
regarding the role of specific hormones in the observed cycle effect on Now bias. First, we did 
not assay PROG or ALLO levels in our subjects, so roles for these hormones in our observed 
behavioral effects cannot be ruled out. Second, E+ samples were only available from a subset of 
participants. Concern on this point is somewhat mitigated by the fact that the subsample from 
whom we were able to measure E+ did not differ from the subsample from whom these samples 
were available. Considering the two subsets as independent samples, this fact could be seen 
instead as a replication of our basic behavioral finding across subsamples, strengthening that 
finding. Third, our method relied on self-report of cycle day, and did not document cycle 
duration or hormonal markers of ovulation across the cycle, which may have substantially 
reduced variance, particularly in the FP. We likely failed to catch the E+ peak in many 
participants, which could substantially diminish effect size. Indeed, among the participants for 
whom we quantified E+, many showed little or no E+ rise from the FP to the MP visit, and the 
effect size was substantially greater in the participants for whom we verified a rise in E+ in the 
FP. More precise monitoring of hormone levels within individuals and targeting behavioral 
measurements to individually determined cycle phases are advised for future research. Finally, 
here we took advantage of the natural “experiment” whereby hormone levels change cyclically. 
While the results suggest a role for E+ in modulating Now bias, direct manipulation of E+ is 
required to establish a causal role. 
Finally, while our finding that E+ interacts with a marker of frontal DA tone is consistent 
with some existing literature, our interpretation of those findings remains speculative. In 
particular, we have no direct evidence that E+ is modulating frontal DA, nor that frontal DA 
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modulates Now bias according to a U-shaped function. Future PET studies of DA signaling are 
needed to test our model. Regardless, our model suggests that the effects of dopaminergic 
medications may be optimized by taking E+ levels and COMT genotype into account. Given the 
large number of conditions treated with such medications, such personalization could have broad 
therapeutic impact.  
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CHAPTER 5: GENERAL DISCUSSION 
 
SUMMARY OF RESEARCH FINDINGS  
Support for inverted-U model relating Now bias to putative PFC DA signaling  
 Over the course of this dissertation work, we have investigated the neurocognitive basis 
of immediate reward selection (Now) bias and the relevance of this behavior as an intermediate 
phenotype for alcohol use disorders. Specifically, we add to the literature that frontal DA as 
indexed by variation in the COMT gene is related to Now bias. We reconciled the divergent 
COMT findings of Boettiger et al. (2007) and Paloyelis et al. (2010) by hypothesizing an 
inverted-U function for the effect of frontal DA on Now bias. Given that DA signaling declines 
with age (Mukherjee et al., 2002; Wahlstrom et al., 2010) and the COMT enzyme activity itself 
is modulated by aging (Tunbridge et al., 2007), we show that the high-activity COMT Met/Met 
polymorphism in late adolescents (ages 18-21) keeps these individuals’ high age-related DA 
levels controlled via enhanced PFC DA clearance. Thus, ICR (our index of heightened Now bias) 
is low in 18-21 Met/Met relative to low-activity COMT Val/Val individuals. The same COMT 
Met/Met polymorphism reduces PFC DA in adults (22-40) to a proposed suboptimal level (as 
age-related tonic DA is lower in adults to begin with), leading to higher ICR in these individuals 
(Figure 2.1). This led to a proposed inverted-U function explaining the relationship between 
tonic PFC DA and Now bias (Figure 2.3). 
 This proposed inverted-U function for the role of PFC DA on ICR was tested in the 
context of naturally-varying dopaminergic signaling across the menstrual cycle in female 
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participants in Chapter 4. We found that as estradiol (and hypothesized DA signaling) rose, ICR 
tended to decline and that this relationship was driven by COMT Val allele carriers with 
proposed lower PFC DA levels (Figure 4.3). Thus, increases in DA-related signaling associated 
with rising estradiol reduced ICR in participants whose proposed tonic PFC DA levels were at 
the left of the inverted-U function. These sub-optimally dosed individuals had the most to gain 
from increased DA-related signaling. Furthermore, considering the age-related differences in 
COMT-related modulation of ICR from Chapter 2, we subdivided our COMT groups into 18-21 
and 22-40 year olds and found that the negative relationship between increasing estradiol and 
decreasing ICR was strongest in 22-40 year old Val carriers with proposed lowest tonic PFC DA 
(far left of the inverted-U function). Conversely, in 18-21 year old COMT Met/Met individuals, 
we found a non-significant but positive relationship between increasing estradiol and ICR (i.e., 
ICR tended to get higher). These individuals would be hypothesized to have the highest PFC DA 
levels (far right of the inverted-U function) and perhaps the boost in DA signaling associated 
with increased estradiol pushed them too far to the right on the inverted-U function where their 
PFC DA was overdosed. While age-related COMT groups in our estradiol study were small and 
we were underpowered to determine if age x COMT effects may have been present in our 
estradiol study, these data point to the utility of our inverted-U function in explaining 
dopaminergic-modulation of Now bias. 
 
Increased Now bias as an intermediate phenotype for AUD risk  
 The importance of understanding the neurobiological basis of Now bias was highlighted 
in Chapter 3 where we show that elevated Now bias may serve as a useful intermediate 
phenotype for AUD risk in adults (26-40). Support for increased Now bias as an intermediate 
phenotype for substance use disorders, including AUDs, has recently been reviewed (MacKillop, 
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2013). A meta-analysis has found Now bias tends to be stronger in those meeting DSM criteria 
for AUDs while subclinical problem alcohol use is associated with modestly elevated Now bias 
(MacKillop et al., 2011). However, only one of the five studies used in the meta-analysis was 
based on a behavioral DD task consisting of a small college-age sample of light and heavy social 
drinkers (Vuchinich and Simpson, 1998). Here, we extend those findings by demonstrating 
problematic drinking (as defined by the Alcohol Use Disorders Identification Test) adults (26-40 
years old) without a self-reported AUD display elevated Now bias compared to light/moderate 
drinkers when controlling for COMT x age effects observed in Chapter 2 (Figure 3.3). The 
degree of Now bias in these problem drinkers was nearly equivalent to that of abstinent 
alcoholics tested previously (Mitchell et al., 2005; Boettiger et al., 2007). Thus, elevated Now 
bias is present in those engaging in risky drinking behaviors before the potential development of 
an AUD. Additionally, we demonstrate adult light/moderate drinkers with at least one first 
degree relative (parent or sibling) with an AUD or possible AUD display heightened Now bias 
relative to those with no family history of AUDs (Figure 3.4). This behavior cannot be explained 
by the individuals’ own drinking behavior as that analysis focused on non-heavy drinkers. While 
this result will need replication due to our relatively small sample size, it is to our knowledge the 
first data lending support to this key intermediate phenotype criterion. Thus, our work provides 
additional evidence that increased Now bias is a useful intermediate phenotype for AUD risk.  
  
Age-related differences in Now bias: Explanation for inconsistent elevated Now bias in 
individuals with a family history of AUDs?   
 In the current work, we found Now bias to be elevated in 18-24 year old “emerging 
adults” regardless of their drinking behavior (Figure 3.3). This age effect occludes the ability to 
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use elevated Now bias as an intermediate phenotype for AUD risk in this population. Also, this 
data suggests the possibility that decreased Now bias may be associated with increased PFC 
structural and functional maturity as this is one of the last structures to complete maturation in 
humans with full development not complete until the early-to-mid twenties (Giedd, 2004; 
Lenroot and Giedd, 2006). We believe our age-dependent Now bias effect, if generalized to other 
studies of Now bias behavior, could explain the lack of consistent effects of family history of 
AUDs on discounting behavior. Most of these family history studies focused on individuals 
under the age of 26 (Crean et al., 2002; Herting et al., 2010) and found very modest to no effect 
of family history status on discounting behavior. A study by Petry et al. (2002) which found 
effects of family history on discounting in females had an average age around 26; thus, this study 
potentially contained enough adult participants (using the definition of 26-40 proposed in 
dissertation Chapter 3) to observe an effect of family history. The fact that Petry et al. observed 
family history effects in females only (Petry et al., 2002) supports the idea that developmental 
“maturity” may be needed to see family history effects as female brains mature earlier than 
males (Lenroot et al., 2007; Lenroot and Giedd, 2010). Thus, future studies of Now bias behavior 
should consider age-related effects on this behavior in addition to other variables of interest. 
Careful control of age distributions across groups of interest (problem drinkers versus non-
problem) will be needed to remove the potential confound of age from future studies.  
 
Role of PFC Dopamine in Now Bias – Direct measures needed 
 Throughout Chapters 2 and 4, we put forward the hypothesis that PFC dopamine (DA) is 
a key modulator of Now bias behavior. We emphasize here that we have inferred the Val
158
Met 
single nucleotide polymorphism (SNP) in the COMT gene is an index of PFC DA tone. There is 
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evidence that this COMT SNP is associated with tonic differences in PFC DA as assessed by 
positron emission tomography (PET) (Wu et al., 2012). We also emphasize that we believe that 
PFC DA level is associated with Now bias according to an inverted-U function where 
intermediate levels of DA are associated with the lowest Now bias. A recent DA depletion study 
has found that COMT SNP predicts the degree to which the depletion of DA affects Now bias 
according to an inverted-U function: those with lower DA tone’s (COMT Val/Val) Now bias 
increased with DA depletion while the high tonic DA group (COMT Met carrier) saw a reduction 
in Now bias with decreased DA (Kelm and Boettiger, 2013). While these data support our 
hypothesis, the specific role of PFC DA and the presence of an inverted-U relationship between 
it and Now bias remain to be tested directly. 
 
Assessing the role of PFC dopamine in Now bias with PET 
 Conducting positron emission (PET) studies using ligands sensitive to DA receptors in 
the PFC, particularly [(18)F]Fallypride (Mukherjee et al., 1995; Mukherjee et al., 1999; Elsinga 
et al., 2006; Riccardi et al., 2008), would allow us to measure the relationship between Now bias 
and D2/3 receptor density across the brain. Fallypride is unique in its ability to image both 
striatal D2/3 receptor as well as extrastriatal receptor binding. Thus, using fallypride PET, we 
could collect DA D2/3 receptor density maps across the age, COMT genotype, and menstrual 
cycle phase to test whether our observed group differences in Now bias across these measures is 
related to PFC DA tone specifically. Previous work with this particular tracer have shown age-
related declines in D2/3 binding (Mukherjee et al., 2002), supportive of the notion that age 
modulates DA signaling.. Interestingly, another study has found that patients with alcohol 
dependence exhibit reduced D2/3 binding in extrastriatal sites including the hippocampus, insula, 
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and temporal cortex relative to age-matched controls and that age-related loss of D2/3 receptors 
was stronger in alcohol dependent individuals (Rominger et al., 2012). Thus, there is evidence 
for both age and alcohol use effects on the DA system. Relating these changes in the DA system 
as assessed by fallypride to Now bias behavior is the next logical step in testing our inverted-U 
model. 
   
Potential role of striatal dopamine in Now bias  
 Striatal dopamine is potentially another factor to consider in our analysis of Now bias 
behavior as frontostriatal loops are critical in reward-based decisions and actions (Haber and 
Knutson, 2010). Using 6-[18F]-fluoro-L-m-tyrosine (FMT) PET to measure DA synthesis 
capacity in various striatal subregions (Jordan et al., 1997), we have preliminary data suggesting 
that those individuals (n=15, 8 male; age 27.7±2.3), with low FMT in the putamen have higher 
Now bias than those with higher levels of FMT, even when covarying for COMT genotype 
(Figure 5.1). Thus, DA tone in the putamen may be a critical mediator of Now bias (ICR). Using 
the same fallypride tracer mentioned previously, we could assess the role of D2/3 DA receptor 
density across the striatum on Now bias and begin to build a model of which frontal and striatal 
regions are critical in dopaminergic-modulation of Now bias.   
 In addition to PET methods for quantifying components of DA signaling across the brain, 
we can study the impact of genetic variations in striatal DA regulators such as the dopamine 
transporter (DAT) on Now bias. DAT is the main means of DA clearance in the striatum and a 
variation in the DAT gene is present in a variable number of tandem repeat (VNTR) elements in 
the 3’ untranslated region of the gene (Vandenbergh et al., 1992). This particular VNTR consists 
of two primary variants, a 9 and 10 repeat (Doucette-Stamm et al., 1995). A recent meta-analysis 
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has shown that the 9 repeat DAT VNTR is associated with greater DAT expression (Faraone et 
al., 2013) and, thus, lower DA tone in the striatum. We have recently genotyped a large group of 
individuals, for whom we have existing Now bias and COMT genotype data, for the DAT VNTR. 
Testing effects of DAT VNTR (DAT 9 repeat carrier versus DAT 10/10 repeat individuals) and 
COMT genotype in 22-40 and 18-21 year olds, we observed a near-significant effect of COMT 
genotype on ICR in adults, F(2,113)=2.97, p=0.056, confirming previous findings (Boettiger et al., 
2007) and those reported in Chapter 2 (COMT Val/Val ICR > Val/Met > Met/Met). In 18-21 
year olds, however, we observed a trend toward the DAT 10/10 repeat individuals displaying 
high ICR relative to the 9 repeat carriers (F(1,99)=3.82, p=0.053) while the COMT effect in this 
age group was not present (F(2,99)=0.68, p=0.51; Figure 5.2). Thus, striatal DA tone as assessed 
via the DAT VNTR may be a more important mediator of Now bias in late adolescents than 
COMT. Further investigation of the relative role of striatal and frontal DA in Now bias across 
individuals and how age may modulate this relationship is needed.  
 
Figure 5.1: Low levels of DA synthesis capacity in bilateral putamen are associated with high 
ICR when controlling for COMT genotype. In a sample of 15 participants with FMT PET 
imaging data, a median split of those with high (n=8) and low (n=7) FMT in the bilateral 
putamen found a significant effect of putamen FMT level on ICR when covarying for 
Val158Met COMT genotype,  F(1,12)=5.27, p=0.041. 
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Figure 5.2: In late adolescents, high ICR is associated with the DAT 10/10 repeat allele, not 
COMT genotype. In individuals 18-21 years old, a near significant effect of DAT VNTR 
genotype on ICR is present, F(1,99)=3.82, p=0.053) while the COMT effect in this age group is not 
present (F(2,99)=0.68, p=0.51). 9-R carrier, 9/9 or 9/10 repeat DAT VNTR; 10/10-R, 10/10 repeat 
DAT VNTR 
 
Differences in task-related activity and Now bias 
 Magnetic resonance imaging technology can take advantage of the different magnetic 
properties of oxygenated and deoxygenated hemoglobin to measure neural activity in humans via 
blood oxygenation level-dependent (BOLD) imaging through a process known as functional 
magnetic resonance imaging (fMRI) (Ogawa et al., 1990; Bandettini et al., 1992). This MRI 
technique is considered functional in that the BOLD signal is collected while human participants 
perform a particular task in the MRI machine and the experimenter can then compare this 
response to estimates of an expected BOLD response to stimuli of interest (those associated with 
when individuals are asked to make a WANT versus objective SOONER/LARGER response in 
our delay discounting task, for instance). These comparisons can be used to generate statistical 
parametric maps of task-related BOLD activity that fits a particular cognitive pattern of interest 
(using the general linear model approach) which can then be compared across individuals in an 
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approach titled statistical parametric mapping (SPM) (Friston et al., 1995a; Friston et al., 1995c; 
Friston et al., 1995b).  
Using a simple regression approach in SPM, Boettiger et al. (2007) identified an area in 
the right lateral orbital frontal cortex (OFC) whose active during DD task WANT choice 
selection was negatively correlated  with Now bias. Additionally, a group of areas including the 
left superior frontal gyrus of the PFC and right supramarginal gyrus of the parietal lobe displayed 
positive WANT activity correlations with Now bias such that these areas were more active in 
individuals with greater Now bias. The PFC and parietal area findings were interpreted as 
reflecting inefficient processing in these areas in high Now bias individuals (Boettiger et al., 
2007). We hypothesized these areas might also be differentially engaged in heavy drinking adults 
and emerging adults found to display elevated Now bias in Chapter 3. We tested whether these 
age and alcohol use groups showing elevated Now bias in our pilot behavioral study (Figure 3.3) 
displayed common BOLD activity patterns during WANT choice selection. We conducted 
simple between group t-tests of activity differences specific for WANT choice selection in heavy 
versus light drinking adults and light drinking emerging adults versus light drinking adults. In 
these comparisons, light drinking adults with previously observed low Now bias served as the 
comparison group against two groups who previously displaying elevated Now bias. These initial 
analyses could provide insight on areas whose activity differentiates individuals with high Now 
bias. Furthermore, findings here would identify areas whose activity changes with age in light 
drinkers (light drinking emerging adult versus adult comparison) as well as areas engaged 
differentially in heavy versus light drinking adults. Overlap between these two activity 
comparisons may also suggest areas in the brain which are sensitive to aging and alcohol effects 
which could be further analyzed to better understand the age by AUDIT-c interaction on Now 
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bias we observed in Figure 3.3. Preliminary results from these comparisons found a region in 
right dorsal PFC (dPFC) (middle frontal gyrus, Brodmann area 9; MNI coordinates 42, 30, 34) 
that was more active in both emerging adult light drinkers and adult heavy drinkers as compared 
to light drinking adults ( Figure 5.3).  
 
 
Figure 5.3: Neural activity is elevated in the right dorsal PFC in groups displaying high ICR,  
Emerging Adults and Heavy Drinking Adults, relative to light drinking adults. Figure reflects 
statistical parametric maps for T-tests comparing WANT versus CONTROL fMRI BOLD 
response activity differences between: A) heavy (n=13, 8 male) and light drinking (n=12, 6 
male) adults B) emerging adult (n=14, 7 male) and adult light drinkers. A region at MNI 
coordinates 42, 30, 34 (crosshairs) showed elevated activity across both comparisons. Color bar 
reflects t test values for each group comparison. p<0.001, uncorrected, 20 voxel extent threshold  
  
Comparing hyperactivity in PFC in groups with elevated Now bias to previous findings 
 The preliminary t-test analyses above represent our initial investigation of neural 
differences associated with elevated Now bias in an ongoing fMRI study of DD behavior in light 
drinking emerging adults, light drinking adults, and heavy drinking adults (see Figure 3.3 for 
AUDIT-c and age criteria used in recruitment). More complex analyses controlling for factors 
that may modulate Now bias (COMT genotype, cycle day, etc…) are planned. We found a 
A) Adults: Heavy Drinkers>Light Drinkers  B) Light Drinkers: Emerging Adults>Adults  
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common area in PFC whose activity was greater in groups previously identified to have elevated 
Now bias. Increased activity in left dPFC has been shown to be positively correlated with Now 
bias and vary with COMT genotype using the same DD task employed here (Boettiger et al., 
2007). Thus, there is convergence for dPFC being an important mediator of Now bias. We 
speculate that hyperactivity in this structure could be associated with inefficient processing 
during the DD task in individuals with elevated Now bias. Thus, the prefrontal control system 
may not function optimally in those individuals with elevated Now bias due to age or drinking 
behavior.  
Following a competing neural systems account of discounting behavior (Bickel et al., 
2007), we hypothesized that those with increased Now bias might show differences in fMRI 
BOLD activity in PFC and striatum while responding to the WANT choice (reflecting 
engagement of a more impulsive brain system during the task) (McClure et al., 2004; McClure et 
al., 2007; Jimura et al., 2013). Differences in task design (Jimura et al., 2013 and McClure et al., 
2004; 2007) and reinforcer type (Jimura et al., 2013 and McClure et al. 2007 consisted of juice 
reinforcement), could explain why we have yet to identify differential striatal activity shared by 
two groups with elevated Now bias (light drinking emerging adults and heavy drinking adults).  
 While our increased dPFC activity across two groups with elevated Now bias is 
promising, a more circuit-level approach to investing differences in fMRI BOLD activity in our 
current dataset is needed. For example, a recent study investigating developmental changes in 
discounting behavior indentified a corticostriatal circuit that mediated behavioral change 
(Christakou et al., 2011). Utilizing approaches such as psychophysiological interaction (Friston 
et al., 1997) or dynamic casual modeling (Lee et al., 2006) to ask how, for example, PFC activity 
modulates striatal function during Now/Later choice could be informative. Furthermore, and 
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particularly relevant to the work presented here, administration of the COMT-inhibitor, 
tolcapone, has been found to reduce Now bias and alter corticostriatal activity (Kayser et al., 
2012). Thus, investigation of brain connectivity differences in the fMRI BOLD data we collect 
both during our DD task and rest (so called, intrinsic functional connectivity (Raichle et al., 
2001; Fox et al., 2005)) to assess neural network differences across groups or variables we think 
may modulate Now bias behavior (Gates and Molenaar, 2012; Smith, 2012) is planned in the 
future. While these approaches are relatively new and must deal with the high dimensional fMRI 
data we collect, they promise to greatly us in identifying neural circuits underlying group 
differences in Now bias behavior in a way the general linear model approach applied in SPM 
cannot (i.e., Figure 5.3). The current and planned neuroimaging analyses (using both fMRI and 
PET) have the goal of providing information on neural mechanisms and targets for Now bias 
reduction, including potential modulation of Now bias via transcranial magnetic stimulation 
(TMS) of dPFC (Figner et al., 2010; Cho et al., 2012) or pharmacological interventions that may 
target areas sensitive to DA modulation. 
        
Implications of our findings for treatments to reduce Now bias  
Our results here are suggestive that PFC DA modulates Now bias and may be one 
potential avenue for reducing this behavior. Reducing Now bias may be particularly useful in 
AUD treatment as we and others (see (MacKillop, 2013) for review) have demonstrated the 
behavior serves as a useful intermediate phenotype for AUDs and could partially explain why 
individuals with AUDs continue to use alcohol (valuing Now) despite knowing the long-term 
consequences of use (discounting Later). Previous studies investigating the role of dopaminergic 
agents on delay discounting behavior have been mixed (de Wit et al., 2002; Hamidovic et al., 
2008). Increases in DA signaling across the brain after d-amphetamine was effective at reducing 
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Now bias (de Wit et al., 2002) while the DA D2/3 (highest affinity for D3) receptor agonist 
pramipexole in a sample of similarly aged healthy participants saw no effect on Now bias. 
Furthermore, the use of buproprion (a non-tricyclic antidepressant drug thought to elevate DA 
signaling by acting primarily as a DAT blocker (Terry and Katz, 1997)) did not alter Now bias in 
a group of healthy smokers and nonsmokers (Acheson and de Wit, 2008). Finally, a recent study 
by Pine et al. (2010) found that L-DOPA (a key precursor in DA synthesis) altered Now bias 
while the DA D2 receptor antagonist haloperidol had not effect (Pine et al., 2010). Thus, the 
literature is suggestive that DA signaling is important in modulating Now bias but not through 
global effects on D2/3 DA receptor signaling.  
More recent studies of Now bias modulation suggest treatments may be more effective if 
targeted specifically at the COMT enzyme itself via tolcapone (Kayser et al., 2012) or if 
dopaminergic interventions are considered in the context of COMT genotype (Kelm and 
Boettiger, 2013). We believe the work we present in this dissertation adds support to the 
importance of taking tonic PFC DA levels and an inverted-U model into account when 
conducting any pharmacological intervention. Thus, screening participants for COMT genotype, 
considering their age, and female estradiol status may all be necessary for more effective 
individualized treatment. Specific interventions such as DA antagonists may be required for 
individuals whose Now bias is elevated due to excess PFC DA while DA agonists may be the 
optimal means of treatment in individuals with insufficient PFC DA. It is possible that more 
selective compounds targeting the D1 receptors critical in PFC goal representation and function 
(Goldman-Rakic et al., 2000; Vijayraghavan et al., 2007) would be more effective in modulating 
Now bias. Unfortunately, such compounds have yet to be approved for use in human populations. 
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Conclusions  
 The ultimate goal of our research program is to better understand the neurobiological 
basis of Now bias to inform attempts to modulate it. We have shown here that Now bias is 
elevated during emerging adulthood (ages 18-24) as well as in adults (aged 26-40) with 
problematic drinking behaviors or with first degree family members with an AUD (Chapter 3). 
Thus, this behavior has the properties of an intermediate phenotype for AUD risk as outlined 
previously (see Introduction; (MacKillop, 2013)). We also provide evidence that variations in the 
COMT gene, a key regulator of PFC DA and function, is associated with Now bias according to 
an inverted-U function (Chapter 2; (Smith and Boettiger, 2012)). This inverted-U relationship 
has been observed in relation to DA’s role in modulating working memory at the level of the 
dorsolateral PFC (dlPFC) in particular (Mattay et al., 2003; Vijayraghavan et al., 2007; Cools 
and D'Esposito, 2011). To further support the critical role of DA signaling in the PFC in 
modulating Now bias, we observed COMT-dependent effects of estradiol on Now bias following 
a similar inverted-U function (Chapter 4) as has been seen in a working memory task known to 
engage the dlPFC (Jacobs and D'Esposito, 2011).  
 These data suggest that PFC DA may be critical in modulating Now bias but direct 
investigation for the role of DA in this behavior using PET techniques (see above) is needed to 
validate our hypothesis. This approach would also allow for the site of action of DA modulation 
of Now bias to be determined and whether complex fronto-striatal circuits which are both 
modulated by DA are involved. Regardless of the site of action and exact neural mechanism of 
our observed effects, our data suggest considering COMT genotype, age, and estradiol levels (as 
a result of cycle phase or various birth control medications) may be critical to determine where 
on our hypothesized inverted-U model individuals with elevated Now bias lie. With this 
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information, we propose that treatments to reduce Now bias may be more effective by 
personalizing interventions (DA agonist versus antagonist) across individuals with potential 
differences in PFC DA (insufficient or excess levels) that may both manifest themselves as 
elevated Now bias. Once an individual’s PFC DA has been returned to an intermediate level, we 
expect Now bias to be reduced. Reducing Now bias may be critical in the context of substance 
abuse by giving individuals with AUDs or elevated AUD risk the ability to look past the 
immediate reward of drinking Now in favor of the long-term health and lifestyle benefits of not 
drinking to excess. 
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